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Part I 
Overview of the Thesis 

This thesis attempts to further clarify some of the issues regarding the use of the absolute 
and relative CFVR. In addition, we search for a more accurate parameter ofluminal 
narrowing. 
Chapter II, III and IV, report the various flow velocity patterns observed prior to, after 
and at 6 month follow-up percutaneous interventions. 
The development of coronary artery dissections is a frequent observation following 
balloon angioplasty. However, very little data is available about the degree of conduit 
obstruction expected in vessels with moderate dissections. In an attempt to describe the 
coronary blood flow characteristics in patients with dissections, we utilized various 
Doppler-derived parameters collected from the DEBATE I and II databases (Chapter V 
and VI). 
Due to the limitations encountered when guiding an intervention with the absolute 
CFVR, we explored the value of coronary blood flow velocity acceleration at the stenotic 
site for predicting clinical and angiographic outcomes (Chapter VII and VIII). 
Shear stress (the friction force exerted by the blood flow towards the coronary 
endothelium) has been linked to the pivotal mechanism involved in the restenosis 
process: 1) vascular remodeling 2) neointirnal proliferation. In Chapter IX, we study the 
prognostic value of the post-procedural averaged shear stress for predicting the clinical 
and angiographic outcome following balloon angioplasty. 
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Chapter1 
INTRODUCTION 

Introduction 
Following the rapid developments in computer software directed towards the 
anatomical assessment of coronary arteries by quantitative coronary angiography 
(QCA), interventional cardiologist felt that the anatomical information obtained was 
sufficient for clinical decision-making. However, further down the line, it became 
clear that QCA presented some limitations especially in patients with diffuse coronary 
artery atherosclerosis. In addition, the presence of haziness at the dilated area 
precluded an accurate estimate of the acute angioplasty results. The latter was further 
supporter by a lack of correlation observed between the QCA and coronary 
physiological data following an intervention. 
Thanks to the pioneer work of Lance Gould and his team, who established the 
relationship between the coronary blood flow resistance and the severity of the 
condnit obstruction, the understanding of coronary physiology and its assessment had 
rapidly evolved. Furthermore, technical improvements have allowed the development 
of miniaturized pressure and Doppler transducers, mounted on 0.014-in. guidewire, 
These small devices did not exert a significant effect in coronary fluid dynamics, 
which permitted an accurate physiological evaluation of percutaneous interventions at 
the catheterization laboratory. 
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Intracoronary Doppler technique 
The Doppler angioplasty guidewire is 0.014" 175 em long flexible and steerable 
guidewire with a floppy shapeable distal end mounting a 12-15 MHz piezoelectric 
transducer at the tip (Cardiometries Inc, Mountain View, CA). The sample volume is 
located at a distance of 5.2 mm from the transducer and has an approximate width of 
2.25 mm due to divergent ultrasound beam so that a large part of the flow velocity 
profile is included in the sample volume also in case of eccentric positions of the 
Doppler guidewire. After real-time processing of the quadrature audio signal a fast-
Fourier transform algorithm is used to increase the reliability of the analysis, the 
Doppler system calculates and displays on-line several spectral variables including the 
instantaneous peak velocity and the time-averaged (mean of 2 beats) peak velocity. 
The flow velocity measurements obtained with this system have been validated in 
vitro and in an animal model using simultaneous electromagnetic flow measurements 
for comparison. Mean flow velocity is calculated as time-averaged peak velocity/2, 
assuming a fully developed flow velocity profile. 
The Doppler guidewire can be used to assess the severity of the lesion to be treated 
before angioplasty or stent implantation. During balloon dilatation, the Doppler 
guidewire is left in place distal to the lesion in order to continuously record the 
Doppler signal and monitor the development of collateral flow, the restoration of flow 
after balloon deflation, the phase of post-occlusive reactive hyperemia and, 
incidentally, the development of flow limiting complications. Immediately after the 
inflation, the balloon is withdrawn into the guiding catheter in order to avoid the 
residual obstruction of flow due to the presence of the deflated balloon across the 
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lesion. The rapid flow velocity increase in the phase of post-occlusion reactive 
hyperemia can be used to assess the adequacy of lumen enlargement post-angioplasty 
innnediately after deflation of the balloon. 
Intracoronary Doppler parameters 
Diastolic-Systolic Velocity Ratio 
In contrast with flow characteristics of other arterial beds, the epicardial coronary 
blood flow has a predominant diastolic pulsatility pattern. During systole, myocardial 
contraction elevates the resistance of the coronary microcirculation translating into a 
diminished systolic blood flow. On the other hand, a greater systolic blood flow 
component is observed at the distal portion of the right coronary artery, in which 
lower compressive forces are observed compared to the left coronary circulation. 
During severe narrowing of an epicardial artery, the diastolic blood flow reduces 
whereas the systolic component of the coronary blood flow increase in an attempt to 
maintain an adequate myocardial perfusion. The latter may be related to changes in 
the intramyocardial volume. Several animal and human studies have described a 
reduction of the diastolic/systolic velocity ratio (DSVR) at the presence of a 
significant stenosis, in which a normalization of the DSVR was seen following 
balloon dilatation. This observation led to the use of the DSVR for the assessment of a 
stenosis and for guidance of percutaneous interventions. However, this ratio has 
shown to have some caveats: 1) it is associated with a high variability, 2) changes in 
contractility would directly affect the ratio results, 3) a significant overlap was 
observed when comparing it to pre-procedural QCA or non-invasive testing data. 
Furthermore, at the DEBATE trial, DSVR carried no additive prognostic value when 
compared to the combination of the absolute CFVR and QCA data. 
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No-Reflow Phenomenon 
In patients with transmural myocardial infarction, unsuccessful reperfusion is not 
always related to the presence of a persistent conduit obstruction, but also due to 
abnormalities of the coronary microcirculation. The occurrence of the no-reflow 
phenomenon following reperfusion therapies represents a good example of the latter. 
The no reflow phenomenon may result from microvascular damage, as suggested by 
myocardial contrast echocardiography performed in patients with TIMI grade 2 flow 
after PTCA. The mechauism for this was suggested by an auimal stndy, which found 
that ischemia resulted in the release of cytokines, especially interleukin-1, which 
stimulated the production of plasminogen activator inhibitor-! and collagen by 
cardiac microvascular endothelial cells. This resulted in impaired fibrinolysis and 
predisposed to the persistence of microvascular thrombi. Other possible mechauisms 
for the no reflow phenomenon are residual stenosis or diffuse alpha-adrenergic 
macrovascular and microvascular vasoconstriction, which impair myocardial blood 
flow and perfusion. 
The differentiation betvveen residual stenosis or microvascular damage as a cause for 
TIMI grade 2 flow has important implications for therapy and left ventricular 
functional recovery. Hence, in patients with TIMI II flow after primary angioplasty, 
the presence of a short diastolic deceleration time plus a systolic retrograde flow 
and/or a very low systolic flow velocity is strongly suggestive of no reflow 
phenomenon (Table I). 
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Table I. Coronary flow patterns in patients with TIMI II flow after primary PICA 
DSVR DDT Systolic flow reversal TIMI Flow with stenting 
Residual stenosis 
NoReflow 
+ +++ 
+++ + 
DDT: indicates diastolic deceleration time. 
Present 
Absent 
Increase 
No Chaoge 
Thus, the DSVR might also be helpful for deciding whether to further dilate aodlor 
implaot a stent versus undergoing measures directed towards the improvement in 
microvascular function (adenosine, glicoproteins IIb/IIIA inhibitors, verapamil, 
nitroglycerin) 
Proximal-to-Distal Flow Velocity Ratio 
In epicardial normal arteries, a modest increase in flow velocity is observed from 
proximal to distal, inversely proportional to the reduction in total cross-sectional area. 
This physiological pattern is distorted with the presence of significaot stenosis. 
Proximal to the stenosis, the blood flow is partially deviated to lower resistance 
braoches, traoslating into a reduction in flow velocity from proximal to distaL This 
observation led to the utilization of the proximal-to-distal flow velocity ratio for the 
hemodynamic evaluation of coronary lesion. In one study, this ratio was around 
1.1±0.2 in aogiographically normal coronary arteries aod 2.4±0.7 in patients with 
significaot stenosis. Similar to the DSVR ratio, normalization was observed after 
coronary aogioplasty. However, significaot overlap was observed between patients 
l7 
Chapter 7 
with limiting and non-limiting coronary lesions. Fnrthermore, absence of side-
branches between the site of the proximal and distal measurements renders this 
parameter rather useless, since both flow velocities would be equal. 
Absolute Coronary Flow Velocity Reserve 
A) Intermediate lesion assessment 
The absolute coronary blood flow velocity reserve (CFVR) is defmed as the ratio of 
hyperemic to resting coronary blood flow velocity. In one study analyzing 150 
angiographically normal arteries in patients with chest pain syndromes, the CFVR 
was approximately 2.9±0.6, whereas in angiographically normal arteries of patients 
with single vessel disease was found to be 2.6±0.95. In that study no significant 
differences were seen between the LAD, LCX or RCA territories. 
In several single-center studies and one multicenter trial, a CFVR<2.0 was reported to 
be strongly correlated with myocardial stress perfusion defects whether assessed by 
2D echocardiography or nuclear imaging. In those studies, the presence of an 
abnormal CFVR had a high sensitivity (86% to 92%), specificity (89% to 100%) and 
predictive accuracy (89% to 100%) for myocardial perfusion deficits. Several studies 
have confirmed that in patients with intermediate lesions and CFVR >2.0 a 
percutaneous intervention could be safely postponed. Nevertheless, the absolute 
CFVR is not only affected by the epicardial conduit size but also by the integrity of 
the coronary microcirculation. In a recent data reported by a Dutch group, the 
microvascular resistance (mean blood pressure I adenosine-induced hyperemic flow) 
was shown to be a primary determinant of the concordance between the absolute 
CFVR>2.0 and the FFR>0.75. Thus, in patients with discordant CFVR and FFR, a 
significantly higher microvascular resistance was found compared to patients with 
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concordant values. Thus, one could argue that a low CFVR might be associated with 
perfusion defects not only because of significant conduit obstruction but also due to 
microvascular dysfunction. This issue remains important since patients with a non-
significant obstruction and severe microcirculatory dysfunction might benefit from 
therapies directed towards improvement of the endothelial dependent and independent 
microcirculatory function. 
Bl Doppler-Guided Angioplasty 
The aim of the DEBATE trial was to identify a Doppler-derived flow parameter, 
which would be able to predict the clinical and angiographic long-term outcome. A 
total of 225 patients underwent sequential intracoronary Doppler assessment prior to 
and after balloon angioplasty and again at 6-month follow-up. In that study, logistic 
regression analysis demonstrated that the combination of CFVR and a residual 
diameter stenosis identifies the best subset group of patients. Thus, the subset of 
patients with best outcome was those with a CFVR >2.5 and aDS% <35%. When that 
subset group was compared to the other 3 groups (DS% >35% with or without a 
CFVR<2.5, DS% <35% with a CFVR<2.5), a significant lower restenosis (16% vs. 
41%, p=0.002) and TLR rate (16% vs. 34%, p=0.002) was found at 6-month follow-
up. Another interesting finding was that the CFVR was lower in those experiencing 
early events (2.73 vs. 2.22, p<0.05). 
Therefore, this landmark study established for the first time that physiclogical data 
carried important prognostic value following a percutaneous intervention. 
Nevertheless, there are some caveats regarding the use of the absolute CFVR for the 
assessment of the degree of residual stenosis: 1) the need for an adequate 
vasodilatation by the coronary microcirculation, 2) its strong dependency on blood 
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pressure and heart rate changes and 3) the presence of an inappropriate elevation of 
resting blood flow velocity potentially underestimating the CFVR results. 
Several alternative uses of the absolute CFVR have also been reported in the literature 
such as acethylcholine-induced CFVR as a surrogate of the endothelial-dependent 
microcirculatory function, following acute myocardial infarction as a marker 
myocardial integrity and prognosis, for the detection of cardiac rejection. However, 
for the purpose of this book, we will focus only on the CFVR results following 
percutaneous interventions. 
Relative Coronary Flow Velocity Reserve: a more lesion-specific physiological 
evaluation 
A) Intermediate lesion assessment: 
Since CFVR is similar at the three major vessel territories, concomitant evaluation of 
the target and a non-treated normal vessel (CFVR target/reference ratio) would 
exclude for abnormalities in CFVR due to hemodynamics or microvascular disease. 
This ratio, the relative CFVR, is claimed to be more lesion-specific than just the 
absolute CFVR. Baumgart et a!. compared the absolute and relative CFVR to the 
Fractional flow reserve (FFR, calculated as the ratio of the absolute distal coronary 
pressure and aortic pressures measured during maximal hyperemia) in 24 coronary 
lesions ranging from 40% to 95%. In that study, ouly the FFR and the relative CFVR 
showed a strong correlation to percent area of stenosis. Furthermore, a close linear 
relationship was found between the relative CFVR and the FFR. However, Pick's 
group did not duplicate these results. They found that the pre-procedural relative 
CFVR was not more useful than absolute CFVR. One may argne that the populations 
were different between the two groups: in Baumgart et al, 18/21 patients had single 
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vessel disease whereas in Piek et al, the great majority had multivessel disease. Maybe 
patients with one vessel disease are more suitable candidates whenever making 
clinical decisions based on the relative CFVR. 
B) Doppler-Guided Angioplasty 
To the best of my knowledge, only one study has been reported showing the predicted 
value of the relative CFVR following percutaneous interventions. In that study, 99 
stented patients followed for 6 months underwent sequential Doppler measurements 
of the target and an angiographically normal reference vessel after balloon angioplasty 
and stent implantation. The cut-offvalue for the absolute and relative CFVR was 2.7 
and 0.88, respectively. Tbe sensitivity, specificity, negative and positive predictive 
value for both cut-offvalnes are depicted in table IL 
Table II. 
Parameter Cut-off Sensitivity Specificity PPV NPV Value 
MLD(mm) 2.65 72% 79% 43% 93% 
%stenosis 11% 83% 61% 32% 94% 
CFVR 2.7 83% 75% 43% 95% 
RCVR 0.88 78% 84% 52% 94% 
RCFVR: indicates relative CFVR, PPV and NPV: positive and negative predictive 
value. 
It appears from this study that patients with CFVR > 2.7 or a relative CFVR >0.88 are 
at very low risk of MACE. 
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Part II 
Doppler Flow Velocity Characteristics 

Chapter2 
Flow Velocity and Predictors of a Suboptimal Coronary Flow 
Velocity Reserve After Coronary Balloon Angioplasty 
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Predictors of Coronary Flow Reserve 
Introduction 
Coronary flow velocity reserve (CFR) has been nsed in the catheterization laboratory 
to assess the changes in coronary blood flow after balloon angioplasty (BA)(l). The 
DEBATE I clinical trial suggested that the risk of clinical and angiographic restenosis 
is significantly lower in patients with optimal BA results defmed as a CFR ;;::2.5 and a 
residual percentage diameter stenosis (DS) ;;::35%, than in patients not fulfilling these 
criteria(2). However, this combined endpoint is not met in more than 50% of patients 
due to a suboptimal CFR(3-5). An elevation of baseline flow, insufficient 
augmentation of the hyperemic flow or a combination of both are accepted 
explanations for a suboptimal CFR. Little is known about acute and long-term flow 
velocity changes in patients achieving or not achieving the optimal CFR after BA. 
Understanding the mechanisms and predictors of a post-procedural suboptimal CFR 
appears to be important for clinical~decision making, e.g. considering strategies of 
provisional stenting. 
Therefore, the aim of the study was to analyze the baseline and hyperemic flow 
velocity changes immediately after BA and at 6 months follow-up and to search for 
independent predictors of a suboptimal result. 
Methods 
Patient Selection 
The methods of the DEBATE trial have been previously described(2). In summary, 
225 patients undergoing BA and sequential Doppler flow velocity assessment were 
included. Patients without complete angiographic and Doppler follow-up (n=42) were 
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excluded from our analysis. The overall remaining population (n=183) was divided 
into 2 groups according to a postprocedural CFR cut-off value of 2.5. A value lower 
than 2.5 was considered as suboptimal result. 
Angioplasty Procedure and Flow Velocity Assessment 
BA was performed according to conventional methods. A 0.014-in Doppler tipped 
guidewire was used as the primary angioplasty guidewire (Flo Wire, Endosonics, 
Rancho Cordova, CA)(6). Measurements of flow velocity (average peak velocity, 
APV) at rest (b-APV) and on maximal hyperemia (h-APV) were performed distal to 
the lesion prior to BA, after BA and at 6 months follow-up. Maximal hyperemia was 
induced by an intracoronary bolus injection of adenosine 12 11gr for the right coronary 
artery and 18 11gr for the left coronary artery system. The CFR was calculated as ratio 
between maximal flow velocity during the peak effect of the adenosine injection and 
the basal flow velocity (h-APV I b-APV). Determination of the end point of the 
angioplasty procedure was based on angiographic criteria (DS<50% in any 
angiographic view), only. 
Quantitative Angiographic Measurement 
Angiographic measurements were done prior to BA, after BA and at 6 months follow-
up. Quantitative assessment of reference diameter (RD), minimal lumen diameter 
(MLD) and diameter stenosis (DS) was performed using multiple projections by an 
independent core laboratory (Cardialysis, BV) utilizing CAAS II analysis software 
(Pie Medical, Mastricht, The Netherlands)[Reiber, 1985 #551; Reiber, 1985 #433]. 
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Statistical Analysis 
Continuous variables are expressed as mean± I SD. Differences within these variables 
before and immediately after PTCA were evaluated by paired Student's !-test. 
Differences between subgroups of patients were evaluated by unpaired Student's t-
test. Categorical data were analyzed using chi-square or Fisher's exact test when 
appropriate. Univariate and multivariate logistic regression analysis was performed to 
search for independent predictors of a suboptimal CFR result. All p-values were two-
tailed, with statistical significance indicated by a value ofp<0.05. 
Results 
Baseline Patients Characteristics 
Patients' baseline characteristics are sunnnarized in Table I. 88 (48%) Patients 
experienced a suboptimal CFR lower than 2.5. This group had higher age and a higher 
proportion of females. 
Angiograpbic Data 
Angiographic lesion characteristics and serial quantitative data are swnmarized in 
Table 2. Similar MLD and DS were observed among the suboptimal and optimal 
CFR group prior to BA, after BA and at 6 months follow-up. The suboptimal CFR 
group showed a trend towards lower RD. 
Changes in Coronary flow Velocity Over Time 
Serial coronary flow velocity measurements are given in Table 3. After BA, both 
groups improved their CFR. The suboptimal CFR group showed a lower diastolic 
blood pressure after BA than the optimal CFR group. In the suboptimal CFR group, 
b-APV values were consistently higher than in the optimal CFR group (prior to BA, 
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after BA and at follow-up) whereas the hyperemic response was diminished after BA 
(figure 1). 
Association Between Angiography and CFR 
Analysis of MLD and CFR measurements showed no correlation after BA (R=0.02, 
p=NS), whereas before angioplasty and at follow-up a significant relationship was 
observed. The Pearson correlation between these 2 parameters prior to BA was 
r=0.491 (p<O.OOl) and r=0.513 (p<O.OOl) at 6 months follow-up (Figure 2). 
Table 1. Baseline Characteristics 
CFR<2.5 CFR>2.5 p-
n=88 n=95 value 
Age (years) 61±9 58±10 0.002 
Male sex 58(67) 85(88) 0.001 
Cardiovascular risk factors 
Current smoking 18(21) 28(29) NS 
Diabetes mellitus 11(13) 11(11) NS 
Hypercholesterolemia 56(48) 54( 57) NS 
Hypertension 32(36) 27(28) NS 
Family history of CAD 40(46) 49(51) NS 
Previous myocardial infarction 15(17) 19(20) NS 
Exertional angioa (CCS*) NS 
Class 1/li 35(53) 68(72) 
Class IIIIN 43(47) 27(28) 
Unstable angioa 47(54) 53( 56) NS. 
Values are given as mean±lSD or as number of patients (proportion of patients%). 
CCS: Exertional angina was categorized according to the classification system of the 
Canadian Cardiovascular Society, CAD: Coronary artery disease 
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Table 2. Angiographic Characteristics and Quantitative Data 
CFR <2.5 CFR>2.5 p-
n~8 n=95 value 
Lesion location LAD 40(45) 46 (48) NS 
LCX 27(31) 21 (23) 
RCA 21(24) 28 (29) 
Type oflesion t A 11(13) 11(12) NS 
B 76(86) 83(87) 
c 1(1) 1(1) 
Reference diameter (nun) 2.79±0.51 2,90±0.42 0.093 
Minima11urnen diameter (nun) pre 1.04±0.30 1.09±0.34 NS 
Diameter stenosis(%) pre 62±9 62±9 NS 
Minima!1urnen diameter (nun) post 1.76±0.40 1.80±0.37 NS 
Diameter stenosis(%) post 37±9 37±8 NS 
Minima!1urnen diameter (nun) fup 1.56±0.52 1.56±0.52 NS 
Diameter stenosis(%) fup 44±14 44±16 NS 
Values are given as mean±lSD or as number of patients (proportion of patients%). 
t Classification according to the American College of Cardiology/ American 
Heart Association task force on the assessment of diagnostic and therapeutic 
cardiovascular procedures. 
LAD: Left anterior descending coronary artery, LCX: Left circumflex coronary 
artery, RCA: Right coronary artery, Pre: Pre-procedural, Post: Postprocedural, 
Pup: 6- Month follow-up 
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Table 3. Serial Coronary Flow Data 
CFR <2.5 (n=88) CFR2:2.5 (n=95) 
Pre-BA Post-BA Follow~u Pre-BA Post-BA Follow-u 
HR (bpm) 71± 12 69±13 t 67.9±11 70±12 68±12t 67±11 
DBP (mmllg) 71±11 70±11 73±11 74±11 74±11* 74±12 
SBP (mmllg) 132±22 128±22 133±21 129±22 125±22 128±22 
b-APV (em/sec) 17±8 22±9t 20±11 15±7 * 15±5* 16±7*t 
h-APV (em/sec) 25±15 43±16' 43±20 25±16 50±17t * 44±18t 
CFR 1.43±0.56 1.95±0.35 t 2.34+0.90t 1.71±0.73 * 3.42±0.76t * 2.84±1.01 *t 
Values are given as mean±l SD. HR: Heart rate, DBP: Diastolic blood pressure, 
SBP: Systolic blood pressure, b-APV: Baseline average peak velocity, h-APV: 
Hyperemic average peak velocity, *p<0.05 vs. CFR<2.5; "! p<0.05 vs pre-BA; t 
p<0.05 vs post-BA 
Predictors of Post-Procedural CFR 
Multivariate logistic regression analysis revealed increasing age (OR 1.071, 95% CI 
1.033 to 1.110, v=0.0002), female gender (OR 2.52, 95% CI 1.204 to 5.291, v=0.014) 
and increasing pre-procedural b-APV (OR 1.056, 95% CI 1.013 to 1.100, p<O.OOl) as 
independent predictors of the post-procedural CFR results. Reference diameter, 
postprocedural MLD, h-APV before BA, postprocedural diastolic blood pressure and 
heart rate were included in the model but did not predict a suboptimal result. 
Discussion 
The major fmding of this study is that a postprocedural suboptimal CFR is related to 
the combination of a transient deficit in hyperemic APV response and a chronically 
elevated baseline APV. 
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Several studies have previously described the changes observed in baseline and 
maximal velocities following BA( 4,5, 7). However, only one study stratified the 
patients according to the CFR ( < or > 2.5) in an attempt to identifY the mechanism 
responsible for a suboptimal result. In that paper, the authors described a transient 
elevation ofb-APV as the only cause for impairment ofCFR(4). However, that study 
is limited due to the relatively small sample size (n~56). In contrast with that study, 
in our analysis, the suboptimal CFR group was associated with a transient deficit in h-
APV and a persistent elevation in b-APV (before BA, after BA and at 6 months 
follow-up) when compared to the optimal group. 
Baseline Velocities and Suboptimal Results 
In our study, patients with suboptimal CFR results were found to be older than the 
optimal group. Czernin et a!. described in healthy elderly volunteers an elevated flow 
at rest and similar hyperemic flow than in the control group(8). Elderly people usually 
present conditions associated with high oxygen consumption, such as high blood 
pressure, decreased arterial distensibility and ventricular hypertrophy, which conld 
lead to a higher baseline flow. Since we found no significant differences in post-
procedural MLD between the optimal and suboptimal group, we could assume that an 
enhanced baseline flow expected in the suboptimal group wonld also translate into 
higher baseline flow velocity. The latter might partially explain the persistent 
elevation ofb-APV found in patients with suboptimal CFR results. 
Although a linear relationship between heart rate and resting flow has already been 
described(9), no relationship between heart rate and baseline flow velocity was found 
in our study. 
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Adenosine-Induced Maximal Velocities Following BA 
Several reports have shown that the presences of a significant hemodynamic 
obstruction in coronary blood flow, microvascular dysfunction or the combination of 
both are the main reasons for a diminished h-APV(I0-13). 
Although similar MLD and DS were found in both groups, a lower CFR was found in 
the suboptimal group throughout the study period. The latter discrepancy between 
anatomy and CFR could be related to differences in the ability to fully vasodilate in 
response to adenosine infusion. In contrast with our results, Kern et a!. reported a 
strong relationship between the residual epicardial obstruction assessed by IVUS and 
postprocedural CFR(7). However, the authors reported no relationship when 
comparing CFR and QCA data after BA, possibly due to the inaccuracy of QCA in 
assessing the functional gain following a percutaneous intervention. 
Recently~ we reported a strong association between the target and reference vessel 
CFR(l4), showing no improvement in CFR with additional stent implantation in 
patients with impaired reference CFR in spite of significant enlargement of the 
epicardial lumen, suggesting that a great deal of the post-procedural CFR results are 
dependent on the microvascnlar function rather than on the anatomical gain. 
Temporary microvascular dysfunction has been associated in the literature to alpha-
adrenergic discharge(l3), platelet-aggregates embolization(15) and microvascular 
stunning. 
Smoothening of the epicardial luminal surface or healing of residual dissections might 
also be responsible for the elevation of the h-APV at 6-month follow-up. This 
controversy could have been clarified by the assessment of the relative CFR (tatget 
vessel CFR divided by the adjacent angiographically normal vessel CFR)(16). 
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Limitations 
The technical limitations in intracoronary Doppler assessment have been described in 
extense. In our study, QCA was used to assess the anatomical gain. However, QCA 
could overestimate the actual functional luminal dimensions. Therefore, intracoronary 
ultrasound (IVUS) imaging or the measurements of the residual transtenotic pressure 
gradient on maximal hyperemia (FFR) would have helped to assess the degree of 
luminal enlargement achieved following BA as well as to exclude the presence of 
dissections missed by the angiography in the suboptimal group as a likely cause of 
residual obstruction(l7). 
In our study, we did not assess if an attenuated hyperemic response would have 
improved with the additional application of Yohimbine infusion. This is especially 
important since the superimposed infusion of Yohimbine after intracoronary injection 
of adenosine has proved to increase an already suspected maximal hyperemic 
response(l8). 
Summary 
In our study a postprocedural suboptimal CFR was related to a chronically elevated b-
APV and a temporary inability to mount an adequate hyperemic response. Elderly and 
female patients as well as patients with elevated pre-procedural b-APV are associated 
with a suboptimal CFR. Further studies combining intracoronary assessment of 
coronary flow velocities and pressure should be designed for a better understanding of 
the different coronary flow impairments following BA. 
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Coronary Flow Reserve and Clinical Outcome 
ABSTRACT 
Background: Analysis of the post-procedural coronary flow velocity changes has 
shov.rn heterogeneous results. We endeavored to quantify the coronary flow velocity 
changes in individuals who underwent percutaneous transluminal coronary 
angioplasty (PTCA) and examined their impact on clinical outcome. 
Methods and Results: As part of the DEBATE II study, 379 patients undergoing 
balloon angioplasty were randomized to additional stent implantation (n=l87) or no 
further treatment (n=l92). All patients were evaluated according to their coronary 
flow velocity reserve (CFVR) results (~.5 and< 2.5) after angioplasty and again at 
the end of the catheterization procedure. A CFVR <2.5 after PTCA was associated 
with an elevated baseline blood flow velocity in both the target artery and reference 
artery. The only independent predictors of an optimal CFVR after angioplasty were 
the CFVR before angioplasty [odds ratio (OR) 2.041, 95% confidence intervals (CI) 
1.297-3.212, p=0.002] and at the non-treated vessel (OR 2.66, 95%CI 1.83-3.85, 
p<O.OO 1 ). A low CFVR at the end of the procedure was an independent predictor of 
major adverse cardiac events (MACE) at 30 days (OR 4.71, 95% CI 1.14 to 25.92, 
p=0.034) and I at year follow-up (OR 2.17, 95% CI 1.22 to 3.85, p=0.008). After 
excluding 30 days MACE~ no differences in MACE at lyear follow-up was observed 
between the patients with and without a CFVR <2.5 at the end of the procedure. 
Conclusions: A low post-procedural CFVR was associated with a worse peri-
procedural outcome, related to microcirculatory disturbances, while there was no 
significant difference at late follow-up. 
Keywords: angiography; intracoronary Doppler; microcirculation 
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CONDENSED ABSTRACT 
The prognostic value and determinants of the postprocedural coronary flow velocity 
reserve (CFVR) was investigated in 379 patients enrolled in the DEBATE II triaL A 
CFVR <2.5 (suboptimal) after PTCA was characterized by an elevated baseline blood 
flow velocity in both the target artery and the reference artery. A suboptimal CFVR 
was correlated with a low pre-procedural and reference CFVR. A low postprocedural 
CFVR predicted major cardiac events (MACE) at 30 and 360 days follow-up. Thus, 
the low post-procedural CFVR was associated with a worse peri-procedural outcome~ 
related to microcirculatory disturbances, while there was no significant difference at 
late follow-up. 
INTRODUCTION 
Coronary flow velocity reserve (CFVR) has been used in the catheterization 
laboratory to assess the physiological stenosis significance and the changes in 
coronary blood flow after balloon angioplastyl. The Debate I trial has recently 
demonstrated that the recurrence of clinical events following angioplasty was 
markedly larger in patients with CFVR <2.5 (24% vs. 12%)2. 
The Debate II clinical trial was designed to test the value of a stategy of provisional 
stenting, defined as stenting only when suboptimal angiographic and CFVR results 
were observed after angioplasty, as compared to a strategy of elective stenting. In 
patients of the DEBATE II study, in whom the CFVR had been monitored throughout 
the procedure~ we analyzed the clinical predictive value of the CFVR for major 
adverse cardiac events (MACE) at short and long-term follow-up. In addition, we 
evaluated the mechanisms and predictors of an optimal CFVR result after 
percutaneous interventions. 
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METHODS 
Patient selection and study objectives 
In summary, patients scheduled to undergo single native coronary angioplasty 
amenable for stent implantation were eligible for tbe DEBATE II trial. Patients with 
total coronary occlusion, ostial, bifurcated or tortuous lesions were excluded from the 
study, as were patients with previous Q-wave infarction in the myocardial territory 
supplied by the target vessel or evolving myocardial infarction in the previous week. 
Every patient provided written informed consent 
A total of618 patients recruited in DEBATE II were randomized to elective stenting 
(n=97) and CFVR and QCA guided coronary angioplasty (n=521 ). Patients without 
Doppler data available (n=l3) or undergoing bailout stenting (n=l29) were excluded 
from the guided-angioplasty group. 
Regardless of the CFVR results after balloon angioplasty, these remaining 379 
patients underv.rent a second randomization to additional stenting (n=l87) or no 
further treatment (n=l92). For the present study, the guided-angioplasty group 
(n=379) was divided according to the absolute CFVR results at the end of the 
percutaneous intervention: optimal (CFVR e:2.5; n=240) and suboptimal (CFVR <2.5; 
n=l39). In contrast to the DEBATE II study protocol, in the present study, QCA data 
following PTCA were not used to defme optimal and suboptimal groups. 
Guided Balloon Angioplasty 
In all patients, QCA and CFVR measurements were performed throughout the 
procedure to achieve an optimal result according to the above-mentioned pre-set 
criteria. 
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Optimal CFVR and QCA were defmed as ::::2..5 and a percentage diameter stenosis 
<35%, respectively. An 'optimal (QCA and CFR) result' was expected to be achieved 
by upsizing the balloon and/or increasing the inflation pressure. Bail-out stenting was 
allowed in the following situations: a residual stenosis of more than 50 percent~ 
dissection type D, E or F, persistent myocardial ischemia along with a dissection type 
C, drop in Thrombolysis in Myocardial Infarction (TIMI) flow grade of at least I 
grade, or Tllv1I grade 0 or 1. After an optimal result was achieved or when further 
attempts to improve the result were deemed unsafe by the operator, the final diameter 
stenosis and coronary flow velocity reserve were assessed. Hereafter, and irrespective 
of these measurements, the second randomization was performed. 
Quantitative Coronary Angiography 
At least two cine angiograms were performed before and repeated in the same 
projections at the end of the procedure. Quantitative angiography was performed 
using edge detection contour (CAAS II system) as described previously. 
CFVR measurement 
A 0.014" Doppler guide wire (Cardiometries FloWire®; EndoSonics, Rancho 
Cordoba, CA, USA) was used. 3 The Doppler wire was advanced distal to the lesion 
and velocity recordings were obtained under basal and hyperemic conditions. 
Maximal hyperemia was induced by an intracoronary bolus injection (12 ~g for the 
right coronary artery and 18 }.Lg for the left coronary artery) or intravenous infusion 
(140 ~g/kglmin) of adenosine. Target vessel Doppler measurements were performed 
prior to and after angioplasty and again following stent implantation. In addition, 
Doppler measurements of an adjacent angiographically normal vessel (less than 30% 
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diameter stenosis) were performed. Absolute CFVR was calculated as the ratio of 
hyperemic to baseline time-averaged peak velocity. Relative CFVR was calculated as 
the ratio of the absolute CFVR in the target vessel to the absolute CFVR in the non-
treated vessel CFVR4. The CFVR was considered normalized when the relative 
CFVR "'0.8 5,6_ 
Endpoints 
For the Debate II study, the efficacy endpoint was a composite of major adverse 
cardiac events within twelve months of the procedure and included: death from any 
cause, non-fatal myocardial infarction and percutaneous or surgical target lesion 
revascularization. Myocardial infarction was defined as the development of a new Q-
wave or a 2-fold rise of serum creatinine kinases together with an abnormal plasma 
level of myocardial isoenzymes. Enzymes were systematically sampled twice within 
the first 24 hours. After hospital discharge, patients were seen at the outpatient clinic 
at 1, 6 and 12 months. Each visit included the recording of the angina status, the 
cardiac medications, a twelve-lead electrocardiogram and a complete physical 
examination. No follow-up angiogram was performed unless clinically indicated. 
Statistical Analysis 
Continuous variables are expressed as mean ± standard deviation, and differences 
between groups of patients were studied using the unpaired Student's t-test or one-way 
analysis of variance, whichever was appropriate. Categorical variables are presented 
as percentages and differences between groups are evaluated using the Fisher's exact 
test, Chi Square or long-rank test whenever appropriate. Odds ratio and 95 percent 
confidence intervals are presented. A 2-tailed paired T test was used to detect 
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variation within patients. Multivariate logistic regression analysis was used to study 
the diagnostic value of the clinical, angiographic with (model I) or without Doppler-
derived data (model 2) to predict an optimal CFVR result. In addition, multivariate 
regression analysis was performed to examine the predictive value of the final 
absolute and relative CFVR for MACE at 30 days and !-year follow-up. All statistical 
tests were 2-tailed and significance was stated at the 0.05 leveL 
RESULTS 
Baseline Characteristics 
Table I illustrates the baseline characteristics of the overall study population. From 
the overall population (n=379), 240 patients appeared to have an optimal CFVR after 
the intervention, defined as a CFVR <:2.5, whereas 139 patients did not meet this 
criterion. Patients with an optimal CFVR result appeared to be slightly younger, with 
a lower percentage of female patients. No significant differences in drug treatment 
prior to the procedure (aspirin, beta blockers, nitrates and calcium-channel blockers) 
were fonnd between patients with and without an optimal CFVR at the end of the 
procedure. Heart rate and double product values were not significantly different when 
comparing patients with and without an impaired CFVR. A total of 308 patients 
underwent CFVR measurements of a reference artery (150 and 158 patients in the 
optimal and suboptimal group, respectively). 
Coronary flow data in the optimal and suboptimal CFVR groups 
As shown in Table II, patients with a CFVR <:2.5 following PTCA had a lower b-
APV (18±9 vs. 22±9, p<0.05) and a higher h-APV (48±18 vs. 43±18, p<0.05) in the 
target artery. In addition, patients with a CFVR <:2.5 had higher CFVR values in the 
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reference artery than patients with a CFVR <2.5 (3.10±0.77 vs. 2.45±0.60, p<O.OOl), 
due to a lower b-APV in the reference artery (14±7 vs. 21±9, p<0.05). Relative CFVR 
was lower in patients with a CFVR <2.5 after completion of the procedure (0.81±0.25 
vs. 1.01±0.34, p<O.OOI). No difference was seen in the angiographical result of the 
intervention between the two groups. Patients with UA had lower CFVR values in the 
reference and target artery after PTCA than patients with stable anginal complaints 
(2.73±0.78 versus 2.93±0.77 and 2.53±0.79 versus 2.74±0.80, respectively; both 
p<0.05). Figure 1 illustrates the significant linear relationship observed between the 
CFVR after PTCA and the reference artery CFVR (p<O.OOl). 
Cardiac enzyme analysis after the intervention 
The level of total Creatine Kinase (CK) was increased in the patients with a CFVR 
<2.5 after PTCA, compared to patients with a CFVR ~.5 (103±233 versus 61±48 
IUIL; p~0.03). Likewise, levels of CK-MB were increased in patients with a 
suboptimal result (11±15 versus 6±6IU!L; p~O.Oll). 
Multivariate predictors of an optimal CFVR after balloon angioplasty 
The patients with optimal CFVR results after balloon angioplasty were younger 
(58±10 vs. 61±11, p<0.05), had a lower female gender proportion (20 vs. 33%, 
p~0.005) and baseline heart rate (66±11 vs. 70±12, p~O.OOI) as well as higher 
diastolic blood pressure (75±16 vs. 72±13, p~0.022) than the suboptimal CFVR 
group. The optimal group presented with a higher baseline CFVR in the target 
(1.73±0.62 vs. 1.37±0.39, p<O.OOOJ) and at the reference artery (3.09±0.72 vs. 
2.50±0.64, p<O.OOOl) compared to the suboptimal group. 
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By multivariate analysis, an elevated diastolic blood pressure and the absence of 
unstable angina were found to be the independent clinical predictors of an optimal 
CFVR result after balloon angioplasty (Table III). However, after including Doppler-
derived data, an elevated diastolic blood pressure and the CFVR values before 
angioplasty and at the non-treated vessel were found to be the only independent 
predictors of an optimal balloon CFVR. (Table III) 
Multivariate predictors of an optimal CFVR after stent implantation 
Patients with optimal CFVR results following stent implantation were younger 
(56±10 vs. 60±11, v=0.024), had a lower smoker proportion (53 vs. 70%, p=O.Ol7) 
and presented with higher diastolic blood pressure (76±13 vs. 71±12, v=0.024) than 
the suboptimal group. Moreover, a higher CFVR at baseline (1.70±0.68 vs. 
1.37±0.33, p<O.OOOl), following angioplasty (2.59±0.69 vs. 1.89±0.50, p<O.OOOl) and 
at the reference vessel (3.11±0.83 vs. 2.41±0.56, p<O.OOOl) was consistently found in 
the optimal when compared to the suboptimal stent CFVR group. 
In addition, the optimal stent group had a greater proportion of eccentric lesions than 
in the suboptimal group (45 vs. 26 %, p=O.Oll, respectively). After adjusting for 
clinical variables, an elevated diastolic blood pressure and the absence of eccentric 
lesions were found to be associated with an optimal CFVR result following stent 
implantation (table IV). After including Doppler-derived variables, the absence of 
eccentric lesions, elevated values of diastolic blood pressure, CFVR values before 
angioplasty and at the reference vessel were found to be independent predictors of an 
optimal stent CFVR result (Table IV). 
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Independent predictors of early and late clinical outcome 
During the first 30 days, the event-free survival was 98% for all patients, 99% (n~l) 
for those with a CFVR :a.5 and 96% (n~7) for those with a CFVR<2.5 (p~0.024). All 
these early events occurred during the first 24 hours (1 death, 4 repeat angioplasty and 
3 periprocedural myocardial infarction). 
The one-year event-free survival was 86% for all patients, 90% for those with a 
CFVIQ2.5 and 82% for those with a CFVR<2.5 at the end of the procedure (p~O.Ol4 
by log-rank test). Figure 2 shows the estimated event-free survival distribution 
according to the CFVR results at the end of the intervention. 
The estimated hazard ratio for MACE at 30 days and at one year for a CFVR<2.5 as 
compared with a CFVR :a.5 was 9.2 (95% CI l.l to 75) and 1.9 (95% CI l.l to 3.4), 
respectively. 
After 30 days, no significant difference in event-free survival was observed bet\veen 
patients with and without an optimal CFVR at the end of the procedure (90% vs. 85%, 
p~O.l39). 
By multivariate logistic analysis, a fmal CFVR <2.5 was an independent predictor 
of MACE at 30 days (OR 4.71, 95% CI l.l4 to 25.92, p~0.034) and l year follow-up 
(OR 2.06, 95% CI 1.16 to 3.66, p~O.Ol4. In addition, final DS was found to be an 
independent predictor of MACE at !-year follow-up (OR 1.04, 95% CI 1.01 to 1.06, 
p~0.003). 
DISCUSSION 
The results of this study show that a suboptimal result after angioplasty (CFVR <2.5) 
is associated with a high risk of early cardiac event. A low CFVR after PTCA is 
determined by the CFR before PTCA in the reference artery, suggestive of pre-
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existing microvascular disturbances as a cause of the low CFVR. Furthermore, the 
association with elevated CK and CK-:MB values suggest that micro-embolization 
may also be operative to explain a low CFVR at the end of the intervention. 
Determinants of impaired CFVR after angioplasty 
In agreement with several studies5-7, we found an elevation of the b-APV as a 
contributing factor for a low post-procedural CFVR. Several mechanisms have been 
postulated for this fmding such as: I) epicardial vasoconstrictionS 2) delay in the 
recovery of autoregulation 1 3) distal embolization of microparticles9 4) post-
occlusive hyperemia. Our data show that a low CFVR after PTCA is determined by 
the CFVR before PTCA and CFVR of the reference artery. This phenomenon may be 
related to several clinical conditions associated with microvascular abnormalities (e.g. 
diabetes mellitus, left ventricular hypertrophy, diffuse atherosclerotic disease). 
Furthermore, our results show elevated CK and CK-MB levels in patients with an 
impaired CFVR after PTCA. This suggests that micro-embolization may serve as an 
alternative explanation for the observed microcirculatory disturbances. 
Animal and human data have shown an enhanced coronary flow following 
miocroembolization 10, 11. This phenomenon appears to be due to adenosine-induced 
hyperemia of the myocardium surrounding the embolized microregions12. This 
interpretation is further supported by a study reporting that patients who experienced a 
prolonged hyperemic response after a percutaneous intervention have been associated 
with higher CPK values than patients without hyperemial3. Equivalent with those 
findings, we found a significant difference of cardiac enzyme levels between the 
patients with an optimal and suboptimal post-procedural CFVR value, as stated. 
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In our study, also a low hyperemic response was also responsible for a suboptimal 
CFVR after balloon angioplasty. The latter has been previously reported, 
underscoring the important role of luminal enlargement for the achievement of an 
adequate CFVR after balloon angioplasty 6,14. 
We found a significant relationship between the target and the reference artery 
CFVR. after stent implantation, further supporting the concept of a strong influence 
exerted by the microcirculation on the post-procedural CFVR results. Therefore, a 
combination of microvascular dysfunction and the severity of the residual stenosis 
appear to explain a post-angioplasty suboptimal CFVR result. Following stent 
implantation, normalization of the CFVR appears to be primarily dependent on the 
integrity of the microcirculatory function. 
Impaired CFVR following angioplasty in relation to clinical outcome 
In the present study, we observed that the early risk of MACE among the patients 
with a CFVR <2.5 at the end of the intervention was 9 times as high as that among the 
patients with an optimal CFVR. After excluding 30 days MACE, no differences in 
MACE at 1 year follow-up was observed between the patients with and without a 
CFVR <2.5 at the end of the procedure. Thus, low post-procedural CFVR was 
associated with a worse peri-procedural outcome, while there was no significant 
difference at late follow-up. 
Although the methods used for the evaluation of the clinical outcome was different 
between our study and DEBATE I, an agreement in acute results was observed 
between both studies. In DEBATE I, a post-procedural CFVR <2.5 was associated 
with a higher recurrence of angina (25% vs. 12%, p=O.l9) and a greater proportion of 
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patients with objective evidence of ischemia (21% vs. 8%, p=0.018) at one-month 
follow-up compared to their counterparts. 
It is conceivable that the elevated risk of early events observed in patients with an 
impaired post-procedural CFVR was not only related to the residual stenosis 
geometry but to microvascular alterations. A low CFVR after PTCA, as an 
independent predictor of clinical outcome, was determined by the CFVR before 
PTCA and CFVR of the reference artery, as stated before. This suggests that pre-
existing microcirculatory disturbances of both the target and reference artery may 
influence clinical outcome after PTCA. Furthermore, the observed elevated cardiac 
enzyme levels in patients with an impaired CFVR after PTCA suggest that micro-
embolization may serve as an alternative explanation for the observed 
microcirculatory disturbances and consequent worse clinical outcome. 
Recent data showed that the relative CFVR appears to be a more specific index of 
persistent conduit obstruction, which may have a role in the postprocedural 
stratification of the coronary blood flow impairments4,5. Moreover, a good long-term 
outcome has recently been reported after stent implantation in patients with a relative 
CFVR >0.88 and minimal lumina! diameter >2.7715. However, in the present study, 
multivariate analysis showed that a low relative CFVR was not associated with an 
enhanced risk of cardiac events neither following angioplasty nor stent implantation. 
these contrasting results might be explained by differences in population size. In the 
latter study, the authors included 150 patients, whereas a total of 308 patients with 
available relative CFVR measurements were included in the present study. 
Stratification of coronary flow impairments according to relative CFVR results 
assumes a uniform microcirculatory functionl6. However, this might not be the case 
even in patients with single vessel disease patients17. 
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LIMITATIONS 
Limitations in Doppler measurements have been extensively described 18. 
In the present study, transtenotic guidewire pressure·derived FFR was not routinely 
performed. In patients with a low relative CFVR FFR could have helped us verify the 
presence of a significant residual conduit obstruction and further understand the role 
of the post-procedural relative CFVR in the guidance of a percutaneous intervention. 
The post-hoc nature of our analysis prevents us from drawing definitive conclusion 
and a prospective evaluation is warranted to further confirm our results. Furthermore, 
this study only included patients with one vessel disease and normal left ventricle 
function. 
CLINICAL IMPLICATIONS 
After balloon angioplasty, an impaired absolute CFVR was due to microcirculatory 
abnormalities and a significant residual anatomical obstruction whereas after 
stenting it was primarily related to a persistent elevation in the baseline velocity. 
The presence of an impaired post-procedural CFVR warrants more closely 
monitoring of patients as it is associated with a worse short-term clinical outcome, 
in particularly during the first 24 hours after the procedure. The latter endorses the 
concept of provisional stenting. 
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Table I. Baseline characterisitcs of the patients with a CFVR ;;,z.s (Group E) and <2.5 
(Group F) at the end of the procedure. 
CFVR ;;,z.s CFVR <2.5 p-value 
Characteristics (n~240) (n~!39) 
Age, years 57±10 61±11 <0.01 
Female gender 50 (21) 44 (32) 0.03 
Diabetes Mellitus 20 (8) 15 (11) NS 
Hypertension 83 (35) 56 (40) ).IS 
Hypercholesterolemia 122 (57) 67 (48) NS 
Previous :MI 66 (28) 49 (35) NS 
Previous angioplasty 23 (10) 17 (12) NS 
Smoking 166 (70) 105 (76) NS 
CCS class 
rm 87 (36) 45 (32) NS 
IIliiV 61 (25) 27 (19) NS 
Unstable angina 71 (30) 55 (40) NS 
Medication 
Lipid lowering 66 (28) 31 (22) NS 
Aspirin 212 (88) 119 (86) NS 
Beta-blockade 158 (66) 88 (63) NS 
Ca-antagonist 115 (48) 71 (51) NS 
Nitrate 157 (65) 87 (63) NS 
Hemodynamics 
Heart rate 68±12 69±12 NS 
Rate-pressure product 6420±1623 6219±1511 NS 
CCS indicates Canadian Cardiovascular Society 
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Table II. Doppler-derived data of the patients with and without a low CFVR after additional stenting 
Group A 
(n=240) 
Group B 
(n~I39) 
Reference Before PTCA After PTCA Reference Before PTCA After PTCA 
DS(%) 68±11 15±11 * 70±11 16±11* 
Relative CFR 0.60::0.27 l.OI±0.34*t 0.58= 0.18 0.81±0.25* 
CFR 3.10±0.77']" 1.71±0.64~· 3.12=0.62*1" 2.45±0.60 1.47::0.36 1.90±0.37* 
b-APV 14±7t 14±7 18±9*~· 21±9 15::tS 22±9* 
h-APV 48±18 23±14 48±18*+ 47±20 21±11 43±18* 
*p<O.OS vs. Before PTCA in the same group "] p<0.05 vs.. simultaneous measurements in group F. 
Group A and B: indicates CFVR "2: or< 2.5 at the end of the procedure. Reference: Reference vessel. b-and h-APV: baseline 
and hyperemic average peak velocities: DS: percentage diameter stenosis 
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Table III. Multivariate predictors of an optimal CFVR following angioplasty 
Variables* 
Unstable angina 
Diastolic blood pressure 
CFVR 
RefCFVR 
Clinical data alone 
Hazard ratio 
(95% CI) 
0.45 (0.23 to 0.90) 
1.04 (1.01 to 1.07) 
P value 
0.02 
0.002 
Clinical and Doppler data 
Ha7..ard ratio 
(95% CI) 
1.04 (1.01 to LOS) 
S.SS (2. 72 to 28.8) 
P value 
0.012 
0.003 
5.91 (2.76 to 12.6) < 0.001 
"' Gender, diabetes, hypertension, previous myocardial infarction or revascularization. functional angina 
baseline heart rate. systolic blood pressure and diameter stenosis. lesion characteristics (angulation. calcification, 
bifurcation. contour) were not independent predictors. CFVR: indicates measurements performed before angioplasty: 
Ref CFVR: measurements performed at the non-treated vesseL 
Coronary Flow Reserve and Clinical Outcome 
Table IV. Multivariate predictors of an optimal CFVR following stent implantation 
Clinical data alone Clinical and Doppler data 
Hazard ratio Hazard ratio 
Variables* (95%CD P value (95% CI) P value 
Diastolic blood pressure 1.04 (1.01 to 1.06) 0.009 1.06 (1.02 to I.IO) 0.004 
Eccentric Lesion 0.39 (0.20 to 0.76) 0.006 0.3! (0.!3 to 0.77) 0.012 
CFVR 8.83 (2.83 to 27.56) 0.00! 
RefCFVR 7.46 (3.37 to !6.53) < 0.001 
*Age, gender. history of diabetes, hypertension. smoking. previous myocardial infarction or revascularization. 
Functional angina class, baseline heart rate, systolic blood pressure and diameter stenosis. lesion characteristics 
(angulation. calcification. bifurcation, contour) were not independent predictors. For abbreviations see table III. 
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Long-term Normalization of Post-procedural Coronary Flow Reserve 
Objectives. We sought to identifY patients with spontaneous long-term normalization 
of impaired CFVR after successful balloon angioplasty to assess a better selection of 
patients that may benefit from adjunctive coronary stent implantation. 
Back,around. Impaired coronary flow reserve (CFVR <2.5) after successful balloon 
angioplasty is a predictor of major adverse cardiac events (MACE) during 6 months 
follow-up. However, spontaneous normalization of impaired CFVR after balloon 
angioplasty may occur. 
Methods. Distal CFVR was measured before and after balloon angioplasty and at 6 
months follow-up in 183 patients studied with single vessel disease using a Doppler guide 
wire. Normalized CFVR at follow-up was defined by its best cutoff value for MACE. 
MACE was defined as death, myocardial infarction or target lesion revascularization. 
Results. Of the patients studied, 88 patients ( 48%) demonstrated an impaired CFVR 
(<2.5) after balloon angioplasty. Impaired CFVR normalized at follow-up (CFVR 
>2.0) in 52 patients (59%), which was related to a better clinical outcome as 
compared to patients with CFVR < 2.0 at follow-up (MACE: 4% vs. 72%, p < 
0.0001). Multiple logistic regression analysis revealed diabetes mellitus and aging 
(>60 yrs) as independent predictors for unchanged impaired CFVR at follow-up. 
Patients with impaired CFVR after balloon angioplasty, without diabetes and age >60 
yrs, demonstrated less MACE at follow-up as compared to those with diabetes and/or 
age >60 yrs (21% vs. 56%; p < 0.0001). 
Conclusions. Spontaneous long-term normalization of CFVR (1:2.0) occurs in 59% of 
patients with impaired CFVR ( <2.5) after successful balloon angioplasty, that is 
associated with favorable clinical outcome. Diabetes mellitus and aging are 
independent predictors of unchanged impaired CFVR (<2.0). 
Keywords: angioplasty blood flow aging diabetes restenosis 
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Abbreviations List 
PTCA 
B-APV 
H-APV 
CFVR 
MACE 
TLR 
DEBATE 
DESTINI 
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=percutaneous transluminal coronary angioplasty 
=baseline average peak velocity 
= hyperemic average peak velocity 
= coronary flow velocity reserve 
=major adverse cardiac events 
=target lesion revascularization 
= Doppler End Points Balloon Angioplasty Trial Europe 
= Doppler End Point Stenting International Investigation 
Long-term Normalization of Post-procedural Coronary Flow Reserve 
Introduction 
The incidence of restenosis (30-50%) following successful conventional balloon 
angioplasty may be reduced by coronary stent implantation due to its favorable effect 
on epicardial remodeling following PTCA. However, neo-intima proliferation is more 
pronounced after stent implantation as compared with balloon angioplasty, which is 
difficult to treat in case of diffuse in-stent restenosis. These considerations have led to 
a revival of conventional balloon angioplasty (1). The clinical outcome following 
balloon angioplasty may be improved using intravascular ultrasound imaging (2,3) or 
intracoronary physiological parameters ( 4-7) for guidance of the procedure. A recent 
published observational multicenter trial, DEBATE- I ( 4 ), revealed two predictors of a 
better long-term clinical outcome after successful balloon angioplasty in patients with 
single vessel disease; i.e. diameter stenosis <35% combined with distal coronary flow 
velocity reserve (CFVR) >2.5 after balloon angioplasty. These combined predictors 
identify patients with a low recurrence of symptoms, a low target lesion 
revascularization rate and a low restenosis rate. Patients with a hemodynamic residual 
lumen obstruction after balloon angioplasty showing an impaired CFVR may benefit 
from additional stent implantation (6-11). However, several studies demonstrated a 
spontaneous normalization of impaired coronary flow velocity reserve during follow-
up (12-15). The aim of the present study is to identifY clinical, angiographic and 
hemodynamic factors that are associated with spontaneous normalization of impaired 
CFVR following balloon angioplasty and to evaluate its relationship with clinical 
outcome. 
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Methods 
Patient selection 
The study population of the DEBATE-I trial consisted of 297 patients undergoing 
balloon angioplasty of a single lesion in a major native coronary artery. Exclusion 
criteria were multivessel disease, previous transmural myocardial infarction in the 
perfusion area of the vessel to be dilated, acute myocardial infarction less than I week 
before PTCA, total coronary occlusion, presence of left bundle-branch block, or 
second- to third degree atrioventricular block, open bypass graft distal to the lesion to 
be dilated, and use of alternative or additional interventional treatments (directional or 
rotational atherectomy, stent implantation, etc.). All patients gave witnessed written 
informed consent, and the interstitutional review boards of all participating centers 
approved the study. 
For a variety of reasons, described in detail elsewhere (4), distal CFVR was measured 
in only 225 patients after successful balloon angioplasty. The study population 
consisted of 183 patients in whom blood flow measurements were completed after 
balloon angioplasty and at 6 months follow-up. Major adverse cardiac events 
(MACE) at 6 months follow-up were defmed as death, myocardial infarction or target 
lesion revascularization. 
Quantitative coronary angiography 
All patients received heparin and acetyl salicylic acid as premedication before 
angioplasty. At least two cineangiograms, in orthogonal directions, were obtained 
before coronary angioplasty and repeated after successful balloon angioplasty 
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(diameter stenosis <50%) and at follow-up in the same directions. Intracoronary 
nitroglycerin 0.1 to 0.3 mg or isosorbide dinitrate 1 to 3 mg was administered to 
achieve maximal coronary vasodilatation. All cinefilms were sent to an independent 
core laboratory, which was blinded to the clinical and Doppler flow velocity results. 
Matched views and frames were selected for off-line quantitative analysis. A 
computer-assisted analysis system was used (CAAS II system, Pie Medical Data). 
Automatic edge detection of the luminal dimensions (MLD and reference diameter) 
and video densitometry analysis (minimal luminal cross-sectional area) were 
performed by use of the guiding catheter filled with contrast as a scaling factor. 
Restenosis was defined as a diameter stenosis >50% at follow-up. 
Intracoronary blood flow velocitv analysis 
All coronary blood flow velocity measurements with the Doppler angioplasty 
guidewire (Flo Wire, Endosonics) were performed as previously described (16). After 
on-line assessment of the baseline average peak velocity (APV), hyperemia was 
induced by administration of an intracoronary bolus of adenosine (12 g in the right 
coronary artery; 18 g in the left coronary artery). Baseline and adenosine-induced 
hyperemic coronary blood flow velocity measurements were performed at the same 
location, verified by coronary angiography, distal to the dilated segment at follow-up. 
CFVR was defined as the ratio of the adenosine induced hyperemic/baseline APV. An 
impaired CFVR after balloon angioplasty was defined as a CFVR <2.5 (4,14). 
Normalized CFVR at follow-up was defined by using the calculated best cut-off value 
for MACE at follow-up. 
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Statistics 
Continuous variables were expressed as mean-lSD. Differences between continuous 
variables were evaluated using the unpaired Student's t test or Mann-Whitney-U test. 
Receiver operating characteristic (ROC) analysis was used to assess the best cut-off 
value ofCFVR at follow-up for MACE. The best cut-offvalues of ROC curves were 
used to translate continuous variables into dichotomous variables for logistic analysis. 
The exact test for 2 x 2 tables was used to compare dichotomous variables. Variables 
with a p-value < 0.1 after univariate logistic analysis was entered in a multivariate 
analysis. This multivariate analysis was performed by means of stepwise logistic 
regression. Statistical analysis was performed with SPSS software for Macintosh 
(version 6.1.1, SPSS Inc., Chicago, Illinois). A p-value < 0.05 was considered 
statistically significant. 
Results 
Patients 
A total of 88 of 183 patients ( 48%) demonstrated an impaired CFVR ( 2.5) after 
successful balloon angioplasty. ROC analysis revealed a CFVR at follow-up of 2.0 
as the best cut-off value for the absence of MACE at follow-up in patients with 
impaired CFVR after successful balloon angioplasty. A total of 52/88 patients (59%) 
with initially impaired CFVR directly after balloon angioplasty demonstrated a 
spontaneous normalization (CFVR :]:2.0) at 6 months follow-up (Fig. 1). The better 
clinical outcomes of these patients as compared to those without a normalization of 
impaired CFVR at follow-up are depicted in Table I. No death or myocardial 
infarction occurred during the 6 months observational period. 
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The percentage diameter stenosis after successful balloon angioplasty, earlier 
mentioned as an independent angie graphic predictor for MACE ( 4), did not influence 
the clinical outcome in patients with normalized CFVR at follow-up; ie, 96% of these 
patients remained free of MACE (Fig. 2). However, patients without normalized 
CFVR at follow-up (CFVR <2.0) and a diameter stenosis >35% after balloon 
angioplasty demonstrated a lower incidence of MACE than patients with DS>35% 
after balloon angioplasty (p = 0.04, Fig. 2). 
Predictors of normalized CFVR 
Univariate analysis of all patient characteristics, angiographic and hemodynamic 
variables resulted in the following variables showing a significant difference between 
patients with normalized CFVR and those without; i.e. age, diabetes mellitus, 
percentage area stenosis (AS) after balloon angioplasty, cross sectional area (CSA) 
after balloon angioplasty and CFVR after balloon angioplasty (Table 2). ROC 
analysis demonstrated the best cutoff values of the above mentioned continuous 
variables age (>60 yrs; 2 = 6.30, p = 0.01), AS before PTCA (>80%; 2 = 3.80, p = 
0.01), CSA after PTCA (<3.08; 2 = 2.27, p = 0.13) and CFVR after PTCA (<1.95; 2 = 
2.29, p = 0.13). Both forward and backward stepwise logistic regression analysis 
revealed the following model of independent predictors for spontaneous normalization 
of impaired CFVR: Legit P= -1.72 + 1.89 (absence of diabetes)+ 0.94 (age 60 yrs). 
The overall accuracy of this regression equation was 89%. 
Influence of diabetes and aging on clinical outcome 
The presence or absence of diabetes in patients with impaired CFVR after balloon 
angioplasty did not show a significant difference in clinical (MACE 6/11 vs. 22/77; p 
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~ 0.08 and recurrence of angina 7/11 vs. 32/77; p ~ 0.18) and angiographic outcome 
(restenosis 5/11 vs. 24/77; p ~ 0.36). The effect of aging (t60 yrs vs. >60 yrs) on 
clinical outcome (MACE 9/41 vs. 19/47; p ~ 0.06 and recurrence of angina 26/44 vs. 
13/44; p ~ 0.007) was more apparent as on angiographic outcome (restenosis 15/46 
vs. 14/42; p ~ 0.88). When both independent predictors were combined, a worse 
clinical outcome was demonstrated in diabetics and/or older patients (>60 years) with 
impaired CFVR after balloon angioplasty (Table 3, Group II+ III+ IV) as compared 
to those t60 years old and without diabetes (Table 3, Group I). The angiographic 
outcome (restenosis) was not influenced by diabetes and aging (Table 3). 
Influence of diabetes and aging and normalized CFVR. 
Diabetes Mellitus. A total of II diabetic patients in the overall DEBATE-I population 
demonstrated impaired CFVR. Impaired CFVR in diabetic patients was related to an 
impaired hyperemic-APV as compared to non-diabetic patients (Table 4). Hyperemic-
APV did not change at follow-up despite a more pronounced late lumen loss as 
compared to the non-diabetic patient group (0.43-0.41 mm vs. 0.15-0.41 mm, p < 
0.05). In contrast, an impaired CFVR after balloon angioplasty in non-diabetic 
patients was due to an increase in baseline-APV, while CFVR at follow-up increased 
in association with a decrease in baseline-APV (Table 4). There was no difference in 
the occurrence of hypertension between patients with or without diabetes (36% vs. 
50%, p ~ 0.51). 
Age. Between the patient groups with and without normalization of impaired CFVR 
both baseline and hyperemic blood flow velocity before and after balloon angioplasty 
were similar in those younger and older than 60 years (Table 5). Moreover, baseline 
blood flow velocity increased after balloon angioplasty in both patient groups. 
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~ 0.08 and recurrence of angina 7/11 vs. 32/77; p ~ 0.18) and angiographic outcome 
(restenosis 5/11 vs. 24/77; p ~ 0.36). The effect of aging ("r60 yrs vs. >60 yrs) on 
clinical outcome (MACE 9/41 vs. 19/47; p ~ 0.06 and recurrence of angina 26/44 vs. 
13/44; p ~ 0.007) was more apparent as on angiographic outcome (restenosis 15/46 
vs. 14/42; p ~ 0.88). When both independent predictors were combined, a worse 
clinical outcome was demonstrated in diabetics and/or older patients (>60 years) with 
impaired CFVR after balloon angioplasty (Table 3, Group II+ III+ IV) as compared 
to those t60 years old and without diabetes (Table 3, Group I). The angiographic 
outcome (restenosis) was not influenced by diabetes and aging (Table 3). 
Influence of diabetes and aging and normalized CFVR. 
Diabetes Mellitus. A total of ll diabetic patients in the overall DEBATE-I population 
demonstrated impaired CFVR. Impaired CFVR in diabetic patients was related to an 
impaired hyperemic-APV as compared to non-diabetic patients (Table 4). Hyperemic-
APV did not change at follow-up despite a more pronounced late lumen loss as 
compared to the non-diabetic patient group (0.43--0.41 mm vs. 0.15--0.41 mm, p < 
0 .05). In contrast, an impaired CFVR after balloon angioplasty in non-diabetic 
patients was due to an increase in baseline-APV, while CFVR at follow-up increased 
in association with a decrease in baseline-APV (Table 4 ). There was no difference in 
the occurrence of hypertension between patients with or without diabetes (36% vs. 
50%, p ~ 0.51). 
Age. Between the patient groups with and without normalization of impaired CFVR 
both baseline and hyperemic blood flow velocity before and after balloon angioplasty 
were similar in those younger and older than 60 years (Table 5). Moreover, baseline 
blood flow velocity increased after balloon angioplasty in both patient groups. 
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However, this increased baseline blood flow velocity normalized at follow-up only in 
patients "j60 years old while hyperemic blood flow velocity remained unchanged 
resulting in a significant increase in CFVR at follow-up (Table 5). 
Discussion 
The rmdings of the present study demonstrate a spontaneous long-term normalization 
of CFVR in 59% of the patients with impaired CFVR after balloon angioplasty. 
Normalized CFVR t2.0 at follow-up was associated with good clinical and 
angiographic outcomes. These clinical outcomes were not influenced by angiographic 
results (DS%) directly after balloon angioplasty. Diabetes mellitus and aging were 
independent negative predictors for normalization of initially impaired CFVR after 
successful balloon angioplasty. Patients >60 years showed a steady high baseline-
APV at follow-up, while diabetics showed a consistent impaired hyperemic-APV at 
follow-up, both resulting in an unchanged impaired CFVR. Patients with impaired 
CFVR after balloon angioplasty, without diabetes and !"60 years old demonstrated 
20% MACE at follow-up, approaching the 16% MACE observed in the original 
presentation of the DEBATE-I study in patients with a diameter stenosis "f35% in 
combination with a CFVR >2.5 after balloon angioplasty. 
Impaired CFVR after successful PTCA 
Numerous studies described a frequent occurrence of impaired CFVR after successful 
balloon angioplasty, varying between 30-61% of their patient population depending 
their definition of impaired CFVR (cut-off values between 2.0 and 3.0) (12,14,15,17). 
In this study, 48% of the patients studied demonstrated impaired CFVR after balloon 
angioplasty, which concurs with previous studies. The majority of our patients (59%) 
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demonstrated a spontaneous normalization of impaired CFVR that may be explained 
by a transient state of a high baseline-APV and/or a transient low hyperemic-APV 
directly after balloon angioplasty. Several clinical studies demonstrated impaired 
CFVR after PTCA due to a transient increase in resting blood flow (13-15,18). 
Several mechanisms have been postnlated for the transient increase in baseline flow 
velocity after balloon angioplasty, such as epicardial vasoconstriction at the site of the 
Doppler guidewire tip mediated by a myogenic response and/or neural mechanisms 
(19,20), the influence of drug therapy (21,22) or a prolonged hyperemic response after 
balloon occlusion. A temporary impaired adenosine-induced hyperemic response may 
be explained by several mechanisms; i.e., remodeling of a residual lumen obstruction 
(23), differences in drug therapy, platelet activation, micro-embolization of platelet 
aggregates (24), release of platelet-mediated vasomotor products that occur after 
angioplasty-induced medial injury (25), and ischemic-induced desensitization for 
exogenous adenosine. 
This is the first study evaluating factors associated with spontaneous normalization of 
impaired CFVR after balloon angioplasty. Both aging and diabetes showed to be 
negative predictors for normalization of CFVR. 
Age. Aging was associated with a stabilized high baseline-APV at follow-up, which 
in combination with a normal hyperemic-APV at follow-up, resulted in an unchanged 
impaired CFVR at follow-up. This high baseline-APV may be explained by an 
increase in systolic blood pressure and heart rate in rest due to an age-related intimal 
thickening of the large arteries and decline in the compliance of the vascular system. 
These increases in systolic blood pressure and heart rate would be expected to elevate 
myocardial oxygen demand and, consequently, blood flow at rest (26,27). However, 
indexes of cardiac work at rest in the present study did not differ between the age-
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determined patient groups (Table 5) that are not consistent with earlier mentioned 
studies. Furthermore, increases in endogenous adenosine release at rest are described 
in aged animals, which may explain increased blood flow at rest. However, this 
hypothesis includes a process of desensitization of the vascular smooth muscle for 
exogenous adenosine resulting in a lower adenosine-induced hyperemic-APV, which 
was not observed in the aged patients of the present study. Moreover, impaired 
angiogenesis is an important age-related and also diabetes-related factor that may 
induce an increase in baseline-APV (28,29). Impaired angiogenesis during ischemic 
coronary disease lowers the capillary density of the ischemic myocardium (30), which 
results in a relative higher oxygen demand that induces an increase in blood flow at 
rest and, consequently, a decrease in CFVR (31 ). 
Diabetes 
In this study, impaired CFVR after balloon angioplasty in diabetics is due to a lower 
hyperemic-APV as compared with non-diabetics with impaired CFVR after balloon 
angioplasty. This finding was consistent with the results of other studies, which 
demonstrated a reduced hyperemic myocardial perfusion by positron emission 
tomography or invasive Doppler-wire measurements in diabetics without a history of 
coronary artery disease (32-34). Reduced hyperemic myocardial blood flow in 
diabetics may be related to a more diffuse state of atherosclerosis and microvascular 
disease undetectable by angiography (35,36). Moreover, the abnormal endothelium-
dependent vasodilatation in diabetics is supported by several mechanisms such as: 
abnormalities in signal transduction, reduced synthesis of EDRF, accelerated 
inactivation of nitric oxide, transport barriers such as thickened basement membranes, 
and generation and release of competing vasoconstrictor substances. 
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In this study, aging >60 yrs and the presence of diabetes demonstrated no recovery of 
impaired CFVR at follow-up due to different disorders in the regulatory mechanism 
of coronary vasomotor tone, and these patients are, therefore, prone to adverse clinical 
events_ 
Diabetes and aging related to clinical outcome in patients with impaired CFVR after 
balloon angioplasty. 
In the DEBATE-I study (4), impaired CFVR after successful balloon angioplasty may 
occur in 48% of the patients treated. According original article of the DEBATE-I 
study, these patients are prone to long-term adverse outcomes and, therefore, subject 
to additional stent implantation. However, the present study provides the clinic 
predictive tools to select a high-risk patient cohort with impaired CFVR after balloon 
angioplasty and long-term adverse outcomes. This cohort of patients exist of patients 
with impaired CFVR in combination with diabetes and/or >60 years of age. These 
patients showed 41% MACE at follow-up and, therefore may benefit from additional 
stent implantation. Contrary, a total of 39 ( 44%, Table 3) patients with impaired 
CFVR after balloon angioplasty were 60 years old and no diabetic. These patients 
showed 21% MACE which almost equalizes the outcome of 16% in patients of the 
DEBATE-I study with DS <35% and CFVR>2.5 after balloon angioplasty (4). So, a 
selected group of 44% of the patients with impaired CFVR after balloon angioplasty 
may maintain from abundant stent implantation. 
Moreover, the strong association between improved CFVR and MACE in the present 
study enlightened the pivotal role of hemodynamic measurements as CFVR, relative 
CFVR (distal CFVR/CFVR of a normal reference vessel) or pressure derived 
fractional flow reserve to predict particularly clinical and not angiographic outcomes. 
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Study limitations 
Intracoronary blood flow velocity assessment is a sensitive technique for the detection 
of alterations in coronary blood flow, but this method is also prone to technical 
failures, and accurate measurements depend on the time, skill, and experience of the 
cardiologist. 
Two different cut-off values for CFVR were used in this article; ie, 2.5 after balloon 
angioplasty and 2.0 at follow-up. Because of the gap between these two cutoff values, 
3 patients showed a "normalization" of their impaired CFVR during follow-up while 
their CFVR decreased during follow-up (Fig. 1 ). However, the cut-off value 2.5 for 
CFVR after balloon angioplasty was determined in patients with single vessel disease 
(DEBATE-I trial (4)), which may agree with a relative CFVR of 0.80 with a mean 
CFVR of approximately 3.1 in the reference vessel (14). In patients with multivessel 
disease a lower cut-offvalue of 2.0 (DESTIN! trial (7)) may be used because of! ower 
CFVR values in the reference coronary artery due to a more extended diffuse 
coronary artery disease (15). Moreover, this is the first study that determined a cutoff 
value for CFVR at long-term follow-up in patients treated with balloon angioplasty. 
This value of 2.0 is the same as the diagnostic cutoff value of CFVR before coronary 
intervention. 
The site of the repeated blood flow velocity measurements was determined by 
angiography, although this method for making repeated measurements may have been 
a contributing factor in the variations noted. 
In the present study, intravascular ultrasound analysis was not performed to evaluate 
the role of remodeling in the normalization process of the CFVR; therefore, this entity 
cannot be ruled out. 
76 
Long-term Normalization of Post-procedural Coronary Flow ReseNe 
It is recognized that the DEBATE-I study was not designed to evaluate the effect of 
diabetes on vasomotor tone, a factor limiting the strengths of our conclusions. 
Potential information as type and duration of diabetes, diabetic medication, glycemic 
control, presence of autonomic neuropathy, grade of retinopathy and left ventricular 
function were not registered. Moreover, this study did not perform histological and 
echocardiographic measurements to evaluate the capillary density and presence of 
diabetic cardiomyopathy. 
An important issue missing is the measurement of the CFVR in an adjacent 
angiographic normal coronary artery to calculate the relative coronary flow velocity 
reserve. Several studies demonstrated also high percentages impaired CFVR values in 
the angiographic normal coronary artery after balloon angioplasty or stent 
implantation (15,17). It is this featnre that may distinguish between global 
abnormalities in the regulation of coronary vascular tone versus blood flow 
abnormalities restricted to the cardiac vascular bed of the dilated coronary artery. 
Clinical implications 
The DEBATE-I study demonstrated a reduced number of MACE in patients with a 
diameter stenosis 35% and CFVR >2.5 directly after balloon angioplasty, which 
legitimized provisional stent implantation in patients with impaired CFVR after 
balloon angioplasty. However, the present study demonstrated a spontaneously 
normalization of CFVR associated with good clinical outcomes in 59% of the patients 
with impaired CFVR, who otherwise were subject to stent implantation. This 
normalization of impaired CFVR occurs independently from the diameter stenosis 
after balloon angioplasty. 
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According their clinical outcome, additional stent implantation may be abundant in 
patients with impaired CFVR after balloon angioplasty, 60 years old and without 
diabetes showed. In contrary, diabetics and elderly with impaired CFVR after 
successful balloon angioplasty did not show an improved CFVR at follow-up and 
were prone to worse angiographic and clinical outcomes. Adjunctive stent 
implantation in these patients remains neither questionable as it may not lower high 
resting blood flow values nor improve impaired hyperemic blood flow values in 
patients with diffuse microvascular coronary disease. Therefore, additional 
measurements of relative CFVR, pressure-derived fractional flow reserve or 
intravascular ultrasound dimensions are necessary to differentiate between residual 
lumen obstruction (suitable for stent implantation) and generalized microvascular 
disease. 
Appendix 
The following investigators and institutions participated in the DEBATE stndy. The 
number enrolled at each center is given in parentheses. 
J.J. Piek, K.T.Koch: Academic Medical Center, Amsterdam, Netherlands (40); E. 
Schroeder, 0. Gum, P. Chenu: Clinique Uuiversitaire de Mont-Godinne, Yvoir, 
Belgium (33); C.Vrints: Uuiversitair Ziekenhuis Antwerpen, Belgium (30); C. di 
Mario, R. Gil, P. Nierop, P.W. Serruys: Thoraxcenter Rotterdam, Netherlands (28); P. 
Probst, G. Porenta: Kardiologische Uuiversit"tsklinik Wien, Austria (25); G. 
Hendrickx, B. de Bruyne, W. Wijns: Onze Lieve Vrouwe Kliniek Aalst, Belgium 
(24); C. Hanet: Clinic Uuiversitaire St Luc, Brussels, Belgium (20); E. Fleck, E. 
W ellnhofer, H. Sauer: Deutsches Herzzentrum Berlin, Germany (17); R. Erbel, M. 
Haude, D. Baumgart: Universit"t Essen, Germany (15); E. Vema: Ospedale di 
Circolo, Varese, Italy (13); V. Voudris, A. Manginas: Onassis Cardiac Surgery 
Center, Athens, Greece (12); H. Geschwind: CHU Henri Mondor, La Creteil, France 
(10); V. M_hlberger, N. Moes, G. Friedrich: Universit"tsklinik fur Innere Medizin 
Innsbr_ck, Austria (9); H. Emanuelsson: Sahlgrenska Hospital G teborg, Sweden (9); 
L. Campolo, G. Danzi: Ospedale Niguarda Ca'Granda,Milano, Italy (6); P. den 
Heijer, H. Peels; Academisch Ziekenhuis Groningen, Netherlands (6). 
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patients 
Figure 1. Individual changes of coronary flow velocity reserve (CFVR) during 6 months 
follow-up (bars) in patients sorted by their impaired CFVR after successful balloon angioplasty 
CFVR at FU 
25 M.~ CE 23 
1 14 
(4%) (61%) 
1 12 
OS 
>3$% (4%) (92%) 
26 13 
Figure 2. The percentage diameter stenosis (DS) after successful PTCA did not correlate with normalization of 
impaired coronary flow velocity reserve (CFVR) at follow-up (p ""'0.19). DS after PTCA did not influence major 
adverse cardiac events (MA.CE) in patients with normalized CFVR at follow-up. However, patients without 
normalized CFVR at follow-up (CFVR <2.0) and a DS 035% after PTCA demonstrated a lower incidence of :MACE 
than patients with DS >35% after PTCA (p"" 0.04). 
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Table I. Differences in long-term clinical outcomes (restenosis, ischemia/angina. M.A.CE) between patients with 
normalized CFVR (>2.0) and those v.ritbout normalized CFVR (<2.0) at follow-up 
CFVR<2.0 CFVR t2.0 Sensitivity Specificity 
(n~36) (n~S2) 
Recurrent AP 26 (72%) 13 (26%) 67% 
Restenosis 23 (64%) 6 (12%) 77% 
MACE 26 (72%) 2 (4%) 93% 
MACE: major adverse cardiac events. similar to target lesion revascularization., 
AP = angina pectoris; CFVR = coronary flow velocity reserve. 
80% 
78% 
83% 
P-value 
<0.0001 
<0.0001 
<0.0001 
Table 2. Univariate analysis of the baseline characteristics between patients with and 
without normalization of a postprocedural impaired CFVR at follow-up. 
CFVR at FU 2.0 CFVR<2.0 P-value 
(n~52) (n~36) 
Patient characteristics 
Male 35 (67%) 25 (69%) 0.83 
Age (yrs) 60-9 64--7 0.03 
Current smoker 13 (25%) 5 (14%) 0.20 
Diabetes Mellitus 2 (4%) 9 (25%) 0.006 
Hypertension 17 (33%) 14 (39%) 0.55 
Unstable angina 25 (48%) 23 (64%) 0.14 
Dyslipidemia 26 (50%) 21 (58%) 0.44 
Hx Myocardial Infarction II (21 %) 4 (II%) 0.22 
Hx Family 25 (48%) 16 (44%) 0.67 
Previous PTCA 6 (12%) 5 (14%) 0.74 
Beta-blockers 30 (58%) 18 (50%) 0.48 
Ca-antagonists 6 (12%) 2 (6%) 0.28 
Nitrates 36 (69%) 27 (75%) 0.56 
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Table 3. Angiographic and hemodynamic characteristics between patients 
with (n~52) and without (n~36) normalization of an impaired CFVR at follow-up 
Variables CFVR~.O CFVR<2.0 P-value 
RCA/LAD/ LCx 15,17,20 9, 17,10 0.71 
Collaterals 5 (10%) 1 (3%) 0.20 
TIMI-flow 2 7 (13%) 2 (6%) 0.20 
Lesion type ACC 1/2/3 8/43/1 4/32/0 0.58 
Lesion length (nun) 8.11-2.40 7.56-2.03 0.27 
Reference Diameter (nun) 2.79-0.42 2.79-0.54 0.97 
DS before PTCA (%) 63-9 61-8 0.13 
AS before PTCA (%) 84-10 79-12 0.05 
DS after PTCA (%) 36-10 37-7 0.60 
AS after PTCA (%) 46-16 48-16 0.73 
Heart rate (bpm) 72-12 70-11 0.56 
MAP(nunHg) 91-15 93-12 0.40 
B-APV before PTCA 16-8 17-7 0.60 
H-APV before PTCA 25-16 22-11 0.32 
CFVR before PTCA 1.5-0.5 1.3-0.4 0.14 
B-APV after PTCA 21-11 23-9 0.48 
H-APV after PTCA 43-16 43-18 0.85 
CFVR after PTCA 2.1-0.3 1.9-0.4 0.06 
RCA ~right coronary artery, LAD ~ left anterior descending, LCx ~ left circumflex, 
TIMI = trombolysis in myocardial infarction, DS = diameter stenosis, 
MLD =minimal lumen diameter, AS = area stenosis, MAP =mean aortic pressure, 
B-APV and H-APV ~baseline and hyperemic average peak velocity. 
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Table 4. The effect of diabetes and aging on hemodynamic, angiographic and clinical 
outcome during 6 months follow-up in patients with impaired CFVR after balloon angioplasty. 
Group I IT m IV ll+ffi+IV 
(n~39) (n~38) (n~2) (n~9) (n~9) 
A ' <60 >60 <60 >60 
DM 0 0 I 
CFVR~.O 30 (77%) 20 (53%) 0(0%) 2 (22%)* 22 (45%)* 
MACE(~TLR) 8 (21 %) 14 (37%) I (50%) 5 (56%)* 20 (41%)* 
Recurrent AP II (29%) 18 (58%)* I (50%) 6 (67%)* 25 (51%)* 
Restenosis 13 (33%) II (30%) I (50%) 4 (44%) 16 (33%) 
* p < 0.05 as compared with group I. Abbreviations as in previous tables, DM: diabetes mellitus. 
Table 5. Influence of diabetes on hemodynamics measured before. after balloon ungioplosty und at follow-up 
in patients with impaired CFVR directly after balloon angioplnsty. 
Absence of diabetes (n~75) Diabetes (n"""ll) 
beforcPTCA afterPTCA follow-up bcforcPTCA nftcrPTCA follow-up 
HR(bpm) 71-12 68-12 68-12 73-10 70-9 68-10 
SBP(mmHg) 131-21 126--21* 133-20 141-31 142-28 134--23 
DBP(mmHg) 71-12 69-10" 73-11 76--13 77-14 71-10 
MAP(rnmHg) 91-13 88-12* 93-12 98-17 98-17 92-13 
HRxMAP (x!O) 647-164 601-155 633--156 719-183 690-145 624-84 
DS(%) 63-8* 37-9 43--14 57-7 35-7 46-15 
:Ml.D(mm) 1.03-0.27 1.76-0.35 1.61--0.45 1.13--0.27 1.82--0.33 1.40--0.• 
B-APV (cm/s) 17-8 22-10 19-8 15-8 19-'i 21-11 
H-APV (cmls) 24-14 44-17* 44-20 20-17 34-10 33-19 
CFVR 1.4-0.5 2.Q....D.3"' 2.4-0.9" 1.2-0.3 1.8-0.4 1.7-0.5 
"p < 0.05 as compared to diabetics., p < 0.05 as compo.red to previous measurement. Abbreviations ns in previous table. 
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lntracoronary Doppler Assessment of Coronary Dissections 
Angiographic: and Clinical Outcome of 
Mild to Moderate Nonoc:clusive 
Unslented Coronary Artery Dissection 
and the Influence on Coronary Flow 
Velocity Reseii'V'e 
Mariano Alberta!, MD, Glenn Van Langen hove, MD, ian Patrick Kay, MD, 
Marco Aurelio Costa, MD, Ken Kozuma, MD, and 
Patrick W. Serruys, MD, PhD, on behalf of the DEBATE I Study Group 
Umited data are available regarding the angiographic 
healing rate and physiologic impact of coronary artery 
dissections. Therefore, we studied the impact of coro-
nary dissections on coronary flow velocity and outcome 
as well as their healing rate at 6-month follow-up bal-
loon angioplasty. Of 297 patients who underwent bal-
loon angioplasty, 225 underwent intracoronary Doppler 
measurements and 184 had Doppler and angiographic 
assessment at 6-month follow-up. Dissections were 
scored by an independent core lab {Cardiolysis BV} and 
divided in 4 groups: mild (types A to Bl, moderate (type 
C}, severe (D to F), and patients without dissections. 
Severe dissections (types 0 to F) were excluded from the 
analysis. Clinicalr angiographic, and Doppler data were 
compared among the remaining 3 patient groups. From 
the 67 dissections detected after balloon angioplasty, 
only 3 (4.5%) remained unhealed at follow-up. lmmedi-
11"4 oro nary artery dissection ranges are observed an-
.._ giograpbically in up to 50% of cases after balloon 
angioplasty .1.1 Although stenting has ended the era of 
urgent surgical revascularization for coronary dissec-
tions impairing distal perfusion,3 most mild to mod-
erate dissections are still left untreated. due to ade-
quate distal filling.Previous studies have shown that 
mild to moderate angiograpbic dissections do not in-
crease the risk of major adverse cardiac events or the 
restenosis rate at 6-month follow-up.4.5 The low rate 
of clinical and angiographic events may be due to the 
healing of nearly all dissections with time, although 
the true frequency of healing remains ill-definedAlso 
of potential prognostic importance is the impact of the 
different types of dissections on coronary physiology. 
Therefore. we investigated the coronary flow velocity 
reserve of the different types of unstented dissections 
after balloon angioplasty and the percentage of heal-
ing at 6-month follow-up. 
ately after balloon angioplasty, the moderate dissection 
group was associated with a lower coronary flow ve-
locity reserve than the patients with mild (2.16 ± 0.60 vs 
2.82 ± 1.00, p = 0.037} or no dissections (2.16 ± 0.60 
vs 2.71 ± 0.88, p = 0.0461, respectively. In oddifion, 
higher recurrence of angina at 30 days was observed in 
the moderate group rather than in the mild group (5 
ISO%] vs 8 116%], p = 0.01601 and in the pofienls 
without dissections (11 [12"/o], p = 0.007}. After s1an-
dard balloon angioplasty, the occurrence of unhealed 
dissections is a rare phenomenon. An impaired coro-
nary Row reserve was observed after the development 
of nonocclusive type C dissections, which was associated 
with a worse short-term oukome. ©2000 by Excerpta 
Medica, Inc. 
(Am J Cardiol 2000;86:375-378) 
METHODS 
The methods and results of the Doppler Endpoints 
Balloon Angioplasty Trial Europe (DEBATE) have 
been previously described6 Briefly. in 297 patients 
who underwent balloon angioplasty of a single lesion 
in a major native coronary artery because of chest pain 
and/or other documented signs of ischemia (electro-
cardiographic, scintigraphic. or echocardiographic) at 
rest or vvith exertion. a Doppler guidewire was used to 
measure basal and maximal hyperemic average peak 
velocities proximal and distal to the stenosis before 
and after angioplasty. For a variety of reasons. such as 
bail-out stenting and protocol violation (Figure 1). the 
recording of distal coronary flow reserve was not 
obtained in 72 of the 297 patients initially enrolled. 
Only angiograpbic criteria (diameter stenosis <50% 
in any angiograpbic view) were used to determine the 
end point of the angioplasty procedure. Flow velocity 
measurements recorded during the procedure were not 
used for guidance of the intervention, although the 
investigators were not blinded to the Doppler results. From the Thoraxcen~er ~otterda~, Dijkzlgt Hospital, Rotterdam, The 
Nethedands. Manuscript received December 17, 1999; revised 
manuscript received and accep~ed February 28, 2000. 
Address :Or reprin~s: Patrick W. Serruys, MD, PhD, Department of 
lnterventional Cardiology, Univer5ify Hospital Dijkzigt, Thoraxcenter 
Bci418, Dr. Molewaterplei~., 4(}3015GD Ro~erdam, The Nether· 
lands. E·mail: serruys@card.azr.:il. 
Follow-up procedures: Within 4 ::!: 2 weeks after the 
initial angioplasty procedure, the patient· s anginal sta-
tus was determined vvith the Canadian Cardiovascular 
Society angina classi:fication.When possible. a symp-
tom-limited bicycle stress test was also performed 
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I 297 I 
~11 I Protocol violation 
~2 I FailedBA 
~ 30 I Stented 
~I I Flow wire not crossed 
~ 28 I Flow wire not recorded 
I 225 I 
FIGURE 1. Flow chart of the initial study enrollment and those 
eligible for clinical, angiographic, and Doppler follow-up. BA = 
balloon angioplasty. 
after withdrawal of all antianginal medication. At 6 
months (:!: 4 weeks), the patient's anginal status was 
re-evaluated. a repeat stress test was perfonned. and 
quantitative angiography (with the same set of matched 
views obtained during the angioplasty procedure) was 
performed. The criteria for reintenrention were based 
on the presence of a percentage diameter stenosis of 
>50% in a patient with either symptoms or signs of 
ischemia. Flow velocity assessment at the time of 
recatheterization was not used in the decision-making 
process. 
Quantitative angiogrophic measurement At least 2 
cine angiograms. in orthogonal projections, were ob-
tained before coronary angioplasty and repeated after 
angioplasty in the same projections. All cine films 
were sent to an independent core laboratory, which 
was blinded to the clinical and the Doppler informa-
tion. Matched views and frames were selected for 
off-line quantitative analysis. A computer-assisted 
analysis system was used (CAAS II system. Pie Med-
ical Data, Maastricht, The Netherlands). Automatic 
edge detection of the luminal dimensions and refer-
ence diameter were performed by use of the guiding 
catheter filledwith contrast as a scaling factor. 
Dissection evaluation: Nonocclusive dissection in-
cidence and grading was detennined by an indepen-
dent core lab (Cardyalisis BV) blinded to flow results 
and clinical outcome according to the National Heart. 
Lung. and Blood Institute classification?: type A 
(small radiolucent area within the vessel). B (nonper-
sisting extravasation of contrast), C (persisting con-
trast medium extravasation). D (spiroid fillingdefect 
with delayed but complete distal flow). E (persistent 
filling defect with delayed anterograde flow). or F 
(fillingdefect with total occlusion). Patients with type 
D. E. or F dissections or any type of dissections 
associated with a Thrombolysis In Myocardial Infarc-
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TABLE 1 Dissection Rota of the Initial and Final Enrollment and 
the Group With Angiographic and Doppler Data Available 
at Follow-Up 
Aoy 
Dissection A B c D E 
lnitiol group (n - 297) 119 50 A6 16 
" 
2 
Enrolled group [n "" 225) 84 36 37 11 
-I 
Follow-up group (n "" 183) 67 30 29 8 
-I 
tion (TIMI) flow grade <3. or with symptoms andfor 
signs of ischemia were excluded from the analysis. 
Most of these patients received bail-out stenting. 
We divided the patients into 3 groups: types A to B 
dissection (mild), type C dissection (moderate). and 
patients without dissections. A comparison of the 
baseline characteristics, and clinical and angiographic 
outcome as well as the coronary flow reserve results 
after balloon angioplasty and at 6-month follow-up 
between the 3 groups was performed. 
Flow velocity measurement: During the angioplasty 
procedure. the Doppler flow velocity spectra were 
recorded continuously on videotape. The Doppler ul-
trasound instrument (FloMap, Cardiometries. Moun-
tain View, California) calculates and displays on-line 
several spectral variables. including the time-averaged 
peak velocity (normalized to the cardiac cycle), the 
average systolic peak velocity. and the ratio of the 
average diastolic to average systolic peak velocities. 
The following ratios were also computed: coronary 
flow reserve. calculated as the ratio between time-
averaged peak velocity during the peak effect of the 
adenosine injection (hyperemic average peak velocity) 
and the baseline time-averaged peak velocity. 
Statistical analysis: The Student's t and chi-square 
tests were performed when appropiate for the compar-
ison of the clinical. angiographic. and Doppler-de-
rived data between the 3 groups. 
RESULTS 
Table I illustrates the dissection rate of the 297 
patients initially screened in our study. the 225 pa-
tients who underwent Doppler measurements after 
balloon angioplasty. and the 184 patients who under-
went angiographic and Doppler measurements at 
6-month follow-up. In this latter group. 67 dissections 
were present after balloon angioplasty and only 3 
(4.5%) persisted at follow-up. Of these 3 patients, 1 
underwent repeat balloon angioplasty of the target 
lesion due to restenosis accompanied by recurrence of 
symptoms: the other 2 patients had no restenosis and 
were event free at 6 months. 
Patient characteristics: Patient baseline characteris-
tics are shown in Table II. All patients had single-
vessel disease. All 3 groups had similar clinical and 
angiographic baseline characteristics. Heart rate and 
diastolic and systolic blood pressure did not differ 
significantlybetween the 3 groups. 
Angiographic and clinical outcome in the different 
dissection types: Clinical and angiographic data are 
summarized in Table m. A113 groups had comparable 
lntracoronary Doppler Assessment of Coronary Dissections 
TABLE II Baseline Characteristics of the Patients With and 
Without Dissections 
A-B Dissection C-D Dissection No Dissection 
(n ""73) (n = 11) {n = 141) 
Age [yrs :1: SO) 59:!: 8 54:!: 10 59± 10 
Moo 44 [78%) 6 [72%) 72 [78%) 
Unstable angina 28 (48%) 4 [50%) 50 {54%) 
TlMI Aow grade 
2 52 (90%) 6 [72%) 86 (93%) 
3 6 (10%) 2 [27%) 6 (7%) 
Typo of lesion 
A 7 [12%) 2 [25%) 11 (12%) 
B 50 [86%) 6 [75%) 81 [88%) 
c 1 [2%) 
Reference diameter 2.89:!:: 0.59 2.86 = 0.65 2.84 ± 0.41 i 
i (mm:!: SD) 
Lesion length (mm 8.44:!: 2.34 9.38:!: 2.28 7.87 ± 2.40 I 
± SD) 
TABLE Ill Clinical and Angiographic Outcome at Six-Month 
Follow-Up 
A-B Dissoction C-D Dissection No Dissection 
(n =59) [o = 80) (n = 116] 
Restenosis 17 [31%) 1 [12%) 32 {35%) 
Angina at 30 d 8 {16%) 4 [50%)• 11 (12%) 
Angina at 6 mo 22 [38%) 1(12%) 39 [42%) 
TlR 15 [26%) 0 (0%) 26 [28%) 
*p <0.05 lor type A to B vorsu~ C-D; p <0.05 no dis:«:tions versus lypo 
C-D. 
TlR = target vossol ravoso:::ulori;:ation. 
major adverse cadiac events, restenosis, and recur-
rence of symptoms at 6-month follow-up. The patients 
with type C dissections had significantlyhigher recur-
rence of angina at 30 days compared with the other 
patient groups (Table III). Of the 4 patients (50%) 
with type C dissections who experienced recurrence of 
angina at 30 days. 3 of 4 (75%) had positive bicycle 
stress tests. All 4 patients were managed medically, 
experiencing no major adverse cardiac events or re-
stenosis at 6 months. None of these 4 patients had 
persistent dissections at follow-up. 
Coronary flow velocity according to dissection type: 
Coronary flow velocity data are sho\VD. in Table IV. 
The patients with type A to B dissections and the 
patients without dissections had comparable coronary 
flow reserve after balloon angioplasty, whereas the 
patients with type C dissections had significantly 
lower coronary flow reserve after balloon angioplasty 
when compared with the other 2 groups. 
The coronary flow reserve at follow-up was similar 
in all groups (see Table IV). Figure 2 illustrates a case 
of a patient who developed type C dissection after 
balloon angioplasty, resulting in an impaired coronary 
flow reserve that improved at 6-month follow-up. 
DISCUSSION 
Our study is the firstone to evaluate the coronary 
flow velocity profileof patients with various types of 
coronary artery dissections, demonstrating a tempo-
rary coronary flowreserve impairment in patients with 
moderate dissections as well as healing of most coronary 
dissections at 6-month follow-up. Cappeletti et al8 have 
recently documented a percentage of healing of 63% (31 
of 49) at 6-month follow-up. The discrepancy with our 
results (95.5% vs 63%) could be due to differences in 
study design: in our study. coronary dissections were 
reviewed off-line by Cardialysis core lab, whereas in 
the Capelletti et al8 study the dissection grade was 
assessed online by the principal operators. 
As with previous studies.-+.5.9 no correlation was 
found between restenosis and the presence of dissec-
tions. Although no difference in clinical events at 6 
months was detected between the 3 groups. the recur-
rence of angina at 30 days was statistically higher in 
patients with type C dissections compared with the A 
to B types and the control group. This findingwas 
further supported by the significantlylower coronary 
flow reserve observed in the type C group compared 
with the other 2 groups, potentially explaining the 
higher incidence of ischemic complications usually 
found shortly after the procedure in patients experi-
encing more severe dissections.7·IO,ll In the present 
study, the limited number of patients with type C 
dissections who experienced early recurrence of an-
gina prevented us from drawing definitiveconclusions 
about the exact incidence and pathophysiologic mech-
anism responsible for the early recurrence in symp-
toms. However. in the patients with early recurrence 
of angina, all previously positive stress tests became 
negative at follow-up, dissections healed. restenosis 
was not observed, and patients experienced improved 
symptoms on medical therapy. All these factors may 
indicate that a temporary disturbance in coronary flow 
had an impact on the early recurrence of angina in 
those patients who developed type C dissections. 
Although a disturbance in coronary blood flow 
velocity was found in the moderate dissection group. 
it did not appear to be due to a residual obstruction as 
demonstrated by similar hyperemic velocities in all 
groups. Furthermore. a lack of improvement in hyper-
emic velocities at follow-up in patients with type C 
dissections, despite the absence of unhealed dissec-
tions or restenosis. argues against a significantresid-
ual obstruction in flow. 
Moreover. the equalization of coronary blood flow 
at follow-up in all groups supports the concept that 
dissections are likely to influence the coronary flow 
and clinical outcome after balloon angioplasty. but 
only in the short term. 
In agreement with previous studies, we found a 
temporary elevation in the baseline average peak ve-
locity as a cause for an impaired coronary flowreserve 
after balloon angioplasty12•13 in the moderate dissec-
tion group that could be related to a delay in the 
recovery of autoregulation,t4 cholesterol emboliza-
tion.15·16 or postocclusive hyperemia. 
Study limitations: Measurements of transstenotic 
pressure gradients on maximal hyperemia were not 
performed~ these measurements would have helped to 
exclude the presence of residual anatomical obstruc-
tion as the cause for the temporary disturbance in 
coronary flow. 
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TABLE IV Procedural and Follow-Up Angiographic and Doppler Flow Data 
A-B Dissection Type C-D Dissection Type No Dissection 
Post-SA FlJ.BA Post-BA FlJ.BA Post-BA FU-BA 
~APV [cm/s) 18 = 7 21:!:: 13 24 = 10'' 19:!:: 11 IB ± 9 17:!:: 7 
~APV [cm/s) 46 = 15 46 ± 20 4B = 13 48:!: 9 47:!:: 18 42 = 19 
CFR [±SD) 2,82 = 1.00 2.52 ± 0.93 2.16 = 0.60'' 2.86 ± 0.87 2.71 ± 0.88 2.55 = 1.52 
DS% [±SD) 37 = 7 42 ± 13 40 = 9 40 ± 12 36:!:: 9 43 = 15 
MLD [mm ± SD) 1.85 ± 0.42 1.61 ± 0.37 1.71 = 0.35 1.68 ± 0.38 1.80 ± 0.32 1.53 ± 0.50 
Acute gain (mm :!:: SD) 0.75 ± 0.29 0.71 ± 0.24 0.71 ± 0.33 
Late loss (mm :!: SD) 0.20 ± 0.37 0.10 ± 0.53 0.26 = 0.44 
*p <0.05 for !ype A to B versus type C to D; t p <0.05 for no dis50Ciions versus iyp{! C to D. 
b-APV = baseline overage peak velocity; CFR =coronary flow reserve; DS% = percentage of diameter stenosis; h-APV =hyperemic average ))E!Ok velocity; MLD = 
minimum luminal diameter. 
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Moderate Dissections and Clinical Outcome 
Uncomplicated moderate coronary artery 
dissections after balloon angioplasty: good 
outcome without stenting 
M Albertal~ G Van Langenhove, E Regar, I P Kay, D Foley, G Sianos, K Kozurna, 
T Beijsterveldt:, S G Cartier, J A Belardi, E Boersma, J E Sousa, B de Bruyne, P W Serruys:o 
on behalf ofLhe DEBATE II Study Group 
Abstract 
Objective--To study the relation be'tWeen moderate coronary dissections, coronary flow velocity 
reserve (CFVR), and long term outcome_ 
Met:hods-523 patients undergoing balloon angioplasty and sequential intracoronary Doppler 
measurements were examined as part ofilie DEBATE II trial (Doppler endpoints balloon an.gio-
plascy trial Europe). After successful balloon angioplascy, patients were randomised 1:0 stenting or 
no further treattnem:. Dissections were graded at the core laboratory by t:Wo observers and 
divided into four categories: none, mild (type A-B), moderate (type C), severe (types D to F). 
Patients with severe dissections (n = 128) or .........l.thout available reference vessel CFVR (n = 139) 
were e..xcluded. Tbe remaining 256 patients were divided into two groups according to the pres-
ence (group A, n = 45) or absence (group B, n = 211) of moderate dissection. 
Results-Following balloon angioplasty, there was no difference in CFVR benveen the t\'OI"o 
groups. At 12 months follow up, a higher rate of major adverse cardiac events was observed over-
all in group A than in group B (10 (22%) v 23 (11 %), p = 0.041). However, the risk of major 
adverse events was similar in the subgroups receiving balloon angioplasty (group A, 6 (19%) v 
group B, 16 (16%), NS). Anlong group A patients, the adverse events risk was greater in those 
randomised to stenting (odds ratios 6.603 v 1.197, p = 0.046), whereas there was no difference 
in risk if the group was analysed according to whether the CFVR was< 2.5 or ;;o:: 2.5 after balloon 
angioplascy. 
Conclusions-Moderate dissections left untreated result in no increased risk of major adverse 
cardiac events. Additional stenting does not llnprove the long term outcome. 
(Heart: 2001;86;193-198) 
Keywords: coron:uy dissection; intr:lcoron:uy Doppler; .o.ngioplascy 
Coronary artery dissection is observed angi-
ographically in up to 50% of cases after balloon 
angioplascy. 1 z Although coronary stenting has 
greatly curbed the need for urgent surgical 
revascularisation for dissections that impair 
distal perfusion, it remains to be established 
whether moderate dissections .........J.th unimpaired 
flow and a good epicardial lumen would benefit 
from additional stenting. Previous studies have 
shovvn that mild to moderate angiographic dis-
sections do not increase the risk of major 
adverse cardiac events or restenosis rate at a si.x 
months follow up after balloon angioplascy. ~ 4 
However, limited data are available on the 
ilnpact of stenting on the short and long term 
clinical outcome after the development of 
moderate dissections. 
We investigated the relation benvecn dissec-
tion after balloon angioplasty and coronary 
flow velocity reserve, and the ilnpact of stenting 
on the subsequent clinical outcome in patients 
treated by balloon angioplascy or stenting in 
the DEBATE II trial (Doppler endpoints 
balloon angioplascy trial Europe). 
Mel:b.ods 
PATIENTS 
Patients scheduled to undergo angioplasty 
because of stable or unstable angina pectoris or 
documented myocardial ischaemia, caused by 
a single de novo coronary stenosis less than 
25 mm long and potentially amenable to stent 
ilnplantation, were eligible for the DEBATE II 
trial. Tbose .........l.th total coronary occlusions,. 
ostial lesions, bifurcated lesions, lesions in a 
previously bypassed vessel, lesions in an 
e.."ttremely tortuous vessel, or lesions containing 
thrombus were excluded from the study, as 
were patients .........l.th previous Q wave infarction 
in the myocardial territory supplied by the tar-
get vessel, or evolving myocardial infarction in 
the previous week. Tbe study was carried out: 
according to the principles of the Declaration 
of Helsinki, and all patients provided written 
informed consent. 
STUDY OBJECTIVES A..'JD DESIGN 
Tbe primary objective of the DEBATE II trial 
was to compare the cost-effectiveness of 
elective stent ilnplantation (primary stenting) 
"W"'ith balloon angioplasty guided by quantitative 
coronary angiography and Doppler flow veloc-
ity measurements. Stent ilnplantation was per-
mitted for bail out situations or whenever an 
«oprim.al result" could not be achieved. Tbe 
secondary objective was to evaluate differences 
in benefits of additional stenting in patients 
"W"'ith and -;.v:ithout an oprim.al result. Tbus a 
double randomisation was required. The first: 
randomisation (1:5) allocated 620 patients to 
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Patients without 
ref CFVR 
n = 139 
Balloon 
group 
n =32 
either primary stenting (n ~ 97) or guided bal-
loon angioplasty (n = 523). All patients in the 
guided balloon angioplasty group who did not 
require bail out stenting (n = 395) underwent a 
second randomisation to additional stenting or 
ternllnation of the procedure. For the purpose 
of our analysis, we selected from the latter 395 
patients all those (n = 256) in whom a 
reference vessel coronary flow velocity reserve 
(CFVR) measurement was available, and 
divided them according to the presence or 
absence of moderate type C dissections (fig 1). 
GUIDED BAlLOON A."'''GIOPlAS'IY 
Doppler flow measurements 
Target vessel Doppler measurements were per-
formed before and after balloon angioplasty 
and again following additional stent implanta-
tion. It was also a requirement to perform a 
Doppler assessment of the CFVR of an 
adjacent angiograpbically non-diseased refer-
ence vessel(< 30% diameter stenosis). A 0.014 
inch (0.36 mm) Doppler guide wire (Cardio-
metries FloWire; EndoSonics, Rancho Cor-
dova, California, USA) was advanced distal to 
the lesion, and velocity recordings were ob-
tained under basal and hyperaemic conditions. 
Ma..:cimum hyperaemia was induced by adeno-
sine, either by an intracoronary bolus injection 
(12 J.Lg for the right coronary artery and 18 J.Lg 
for the left coronary artery) or by intravenous 
infusion (140 J.Lg/kg/min). Absolute CFVR was 
calculated as the ratio of hyperaemic to 
baseline time averaged peak velocity. Relative 
Guided balloon 
angioplasty 
n = 523 
Stent 
Bail-out stenting 
n= 128 
Stent 
group 
n = 111 
Moderate dissection groups Non-moderate dissection groups 
F1i:z,= I Study popul.ruiqn.. All patients alkJcated to the guided balkxm angioplasty group 
of the DEBATE II trial who did nor require bail ow; sr:eming formed the populmion for our 
suhstwiy (395 paticms). Of these_, 139 had rw daUJ uf the reference =sd curonary for..o 
vclodry rescr.x =ailable ami were therifore excluded from jurr.her analysis. The -remaining 
256 patient.> wuier..ol:nl a =d rr:mdamisation to addirWna1 stenring or termination of the 
procedure. Wii analysed these paticms depending on the presence (group A) or absence 
(group B) of =pliea!ed ''moderate" dissecti=. 
100 
CFVR was calculated as the ratio of the abso-
lute CFVR to the non-diseased reference vessel 
CFVR 
Quantitative coronary angiography 
Intracoronary g:lyceryl trinitrate 0.1-0.3 mg or 
isosorbide dinitrate 1-3 mg was given to 
achieve maximum coronary vasodilatation. At 
least two cineangiograms were performed 
before the angioplasty or stenting procedure 
and were repeated in the same projections 
afterwards. Quantitative angiography was per-
formed using a standardised protocol de-
scn"bed previously.' 6 
Dcfi:nir:ion of an "optimal" result 
An "optimal" result (on quantitative angio-
graphy and coronary flow reserve determina-
tion) was defined as a diameter stenosis of 
< 35% and a coronary flow reserve of > 2.5/ 
and was achieved by upsizing the balloon or 
increasing the inflation pressure, or both, if 
necessary. 
BAll.. OUT STENTIN'G 
Bail out stenting was allowed in the following 
situations: a residual stenosis of more than 
50%; dissection of zype D, E, or F; persistent 
myocardial ischaemia along with a dissection 
type C; a fall in thrombolysis in myocardial inf-
arction (TIMI) flow grade of at least one grade; 
or TIMI grade 0 or 1. 
SECO:t-."D RA.'IDOMISATION 
Mter an optimal result was achieved or when 
further attempts to improve the result were 
deemed unsafe by the operator, the final diam-
eter stenosis and coronary flow velocity reserve 
were assessed. Thereafter, and irrespective of 
these measurements, the second randomisa-
tion was performed. 
DISSECTION EVALUATION 
Intimal dissection incidence and grading was 
determined by an independent core laboratory 
(Cardialysis BV) classification,' blinded to 
Doppler flow results and clinical outcome, 
according to the National Heart, Lung, and 
Blood Institute (}.'1ll...BI) classification: 
o type A: small radiolucent area withln the 
vessel; 
• type B: no persisting e.'\."travasations of 
contrast; 
• type C: persisting contrast medium e..-rrava-
sations; 
• type D: spiral filling defect with delayed but 
complete distal flow; 
o type E: persistent filling defect with delayed 
antegrade flow; 
o zype F: :filling defect with total occlusion. 
Dissections were clinically divided into 
"mild" dissections (type A or B), "moderate" 
dissections (type C without signs or symptoms 
of ischaemia), or "severe" dissections (cype C 
with symptoms or signs of ischaemia plus types 
D to F). The patient populution was analysed 
on the basis of the presence (group A) or 
absence (group B) of uncomplicated moderate 
dissections. 
Moderate Dissections and Clinical Outcome 
EFFICACY E!'>.'D POn-.'TS 
For the DEBATE IT study, the efficacy end 
point was a composite of lll:ljor adverse cardiac 
events within 12 months after the procedure 
and included the following: death from any 
cause, non-fatal myocardial infarction, and 
percutaneous or surgical target lesion revascu-
brisation. After hospital discharge, patients 
were seen at the outpatient clinic at one, si."=, 
and 12 months. No follow up angiogram was 
performed unless clinically indicated. 
STATISTICAL A."fALYSIS 
Continuous variables are expressed as mean 
(SD), and differences between groups of 
patients were studied using the unpaired 
Student's t test or one way analysis of variance, 
as appropriate. Categorical variables are pre-
sented as percentages, and differences between 
groups were evaluated using the i rest or Fish-
er's e..xact test. Multivariate logistic regression 
analysis was used to study the value of the 
clinical, angiographic, and Doppler derived 
data to predict major adverse cardiac events at 
the 12 months follow up. Odds ratios and 95% 
confidence intervals (CI) are presented. The 
Breslow-Day test was used to assess the homo-
geneity of odds ratios between subgroups. The 
Table 1 Baseline characteristics of the patients according to dissccrUm SCIJTc folkr..ving 
baJJmm. angiopl=y 
Dissection 
'JYpcC(graupA) NtmdrypcA-B (J:Y!'UPB) 
Charac.rcrislic (n=45) (n:=2J1) p J...alue 
Age (ye:ll'll) (mean (SD)) 62 (11) 57 (11) 0.011 
Fcmnleeex 33 (73%) 157 (74%) :t-::5 
Diubetes mellitun 3 (7%) 23 (11%) NS 
Fnmily bistOJ1' 21 (47%) 73 (35%) ~s 
Hypen<=lion 14(31%) 86 (41%) xs 
Hypercl!oleatcrolacmiu 21 (47%) 117 (55%) l":S 
Smoking 23 (S1%) 14S (69%) 0.014 
CCS functional elwls NS 
I 3 (9%) 8 (7%) 
rr 19 (56%) 61 (SO%) 
lil 11 (32%) 46 (38%) 
IV 1 (3%) 6 (S%) 
t:"n~table anginn .. 11 (32%) 89 (42%) NS 
V:!lue:; ru:e n (%) unles• stnted. 
CCS, Cltlllld.ian Ctu:dJOVMcular Society; type C, modem~ dissection; type A-B, very minor 
di<~ection. 
"Pu.ticnm with llll>'tnble nnginu w= excluded from the annl)llli• of the CCS functional clnss. 
Disscaicm 
TypeC(J:YmlpA) Nom/type A-S 
Characteristic (n=l5) (J:Y!'UP B) (n"'211) p J...alue 
&centricity y~ 31 (69%) 12S (60%) 
:-<o IS (31%) 85 (40%) xs 
L="" <lOmm 23 (51%) 9S (49%) ::>IOmm Z2 (49%) 92 (47%) 
'" 
Accessibility Xo tonuo~icy 43 (93%) ISO (86%) 
Mode:mte 3 (6%} 
tonuo><ity 28 {13%) 
Exe""u tonuosiry 2 {I) NS 
Angulation .. None 41 (S9%) ISS (88%) 
Mode:mte s (11%) 25 (12%) 
Severe bend point 0 0 NS 
Cnlc::iJi.c;ation Little or none 39 (85%) 198 (94%) 
Moderntc to heavy 7 (IS%) 12 (6%) 0.026 
Vnlues lire mean(%). 
"None,< 45°; mode:mte, > 45° to 90"; m:vere, > 90°. 
log rank test was applied to study differences in 
event-free survival between subgroups at the 
12 months follow up. All statistical tests were 
two tailed, and significance was assumed at 
p < 0.05. 
Results 
From 523 patients randomised to the guided 
angioplasty group in the DEBATE ll trial, 128 
underwent bail out stenting: because of severe 
dissections. All the remaining patients 
(n = 395), irrespective of the presence or 
absence of a moderate dissection, underwent a 
second randomisation to additional stenting or 
tohalringtheprocedurc. Of these 395 patients, 
139 were e.xcluded from our analysis because 
no reference CFVR measurements were avail-
able. The remaining 256 patients were divided 
into two groups according the presence (group 
A, n = 45) or absence (group B, n = 2II) of 
uncomplicated moderate dissections (fig I). 
BASE"L!l..""E CHARACTERISTICS 
Patients' baseline characteristics are summa-
rised in table 1. Patients in group A were older 
and had a smaller proportion of smokers than 
those in group B. 
Lesion characteristics are given in table 2. 
Group A had a greater proportion of calcified 
lesions than group B. Both groups had similar 
vessel size (mean (SD): 2.93 (0.43) mm v 3.03 
(0.59) mm, group A v group B, respectively 
(NS)). In group B, 110 of the 211 patients 
(53%) had no dissection, whereas 101 (47%) 
showed "mild" dissections. 
Stent length was similar in both groups 
(16.3 mm v 15.6 mm in groups A and B, 
respectively; p = 0.64). 
CORONARY DISSECTIO::<r SEVERIIY A.."'ID CORONARY 
FLOW 
For both groups, baseline and hyperaemic 
averaged peak velocity values before and after 
the procedure are given in fig 2. The preinter-
ventional hyperaemic response was slightly 
impaired in the group A patients randomised to 
stenting. Mter balloon angioplasry, both 
groups showed similar baseline and hyperae-
mic averaged peak velocity values. In patients 
randomised to additional stent implantation, 
no differences in baseline and hyperaemic 
averaged peak velocities were seen. 
Absolute and relative CFVR values are given 
in table 3. Before and after balloon :mgioplasty, 
absolute CFVR was similar in the patient 
population as a whole. However, in the 
subgroup randomised to stenting, the absolute 
CFVR was lower in group A than in group B. 
As the non-diseased reference vessel CFVR 
was also significantly lower in group A than in 
group B (2.43 (0.71) v 2.91 (0.78),p < 0.001), 
the resulting relative CFVR after stent implan-
tation was similar in the tw"o groups. 
CORO::<rARY DISSECTIO~ SEVERITY A.."'ID c:r.n..""ICIU. 
OUTCOME 
Complete follow up data were obtained in all 
patients. Thirty three cardiac events occurred. 
There were five deaths (one in group A and 
four in group B) and si."'= myocardial infarcts 
l 01 
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Figure 2 Baseline (0-APJI) and Jl)'j)<:Taemie (11-APV) average peak velocities bifore and after rJu: procedure in group A 
and group B. Upper paw:ls shtr.JJ the subgroup randamiscd w stopping the procedure after ballmm ant:Wplasry (BA); lo-.i!i:r 
paru:fs slur.» the subgroup randomiscd w further stem impkmuaion (stent). 
(one in group A and five in group B). At 12 
months, the rate of target lesion revascularisa-
tion and major adverse cardiac events was 
higher in group A than in group B (table 4). 
Event-free survival at 12 months was 78% in 
group A v 89% in group B (p = 0.041). 
AJ1 variables for which univariate analysis 
yielded a signifie3nt difference (age, smoking, 
degree oflesion calcification) were entered into 
the multivariate logistic model as potential 
predictors of major adverse cardiac events, 
Table 3 Coronary forJJ velocity da!a 
Group A GroupS 
S=- Ballo<m group Su:mr;rou.p Balloon group (n=l::l) (n=32) (no;;JJJ) (n=JOO) 
DS before BA (%) 76 (7) 69 (11) 68 (lO)t 68 (II) 
DSnft<'rBA(%) 23 (8) 23 (7) 22 (10) 21 (8) 
DS nfter stcntin>; (%) 7 (9} 8 (8) 
CFVR befor~ BA 1.29 (0.32)* 1.55 (0.52) 1.1)4 (0.61) l.M(0.60) 
CFVRnfterBA 2.04 (0.59) .. 2.65 (0.95) 2.50 (0.74) 2.50 (0.73) 
CFVR nfter stentin!l; 2.33 (0.87) 2.88 (0.30lt 
RCFVR befor~ BA 0.57 (0.21) 0.57 (0.19) 0.60 (0.25) 0.58 (0.21) 
RCFVRnfterBA 0.86 (0.17) 1.00 (0.28) 0.89 (0.27) 0.89 (0.27)7 
RCFVR nfter •tentinJ:; 0.97 (0.24) 1.02 (0.30) 
ReferenceCFVR 2.43 (0.71) .. 2.83 (0.81) 2.91 (0.78lt 2.90 (0.75) 
Vulues are menn (SD). 
*p < 0.05 v bnlloon group A;, tp < 0.05 v =c subgroup in group·"'-
BA, bnlloon :mgioplnscy; CF\IR, coronnry flow velocity reBerve; DS, p<'tcenmg~ diru:net<'t •tenofi1J; 
group A. patienta with modemtc cfusectiom; group B, pntientt> with no or minimol dissection; 
RCFVR, relm:ive CFVR. 
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along with the presence of moderate dissec-
tions. The presence of moderate dissections 
was the only independent predictor of major 
adverse cardiac events (odds ratio 2.42; 95% 
CI, 1.06 to 5.57;p = 0.036). 
L'>1PAcr OF S'fEt.."TTJ\':G 0::-.:r MODERATE 
DISSECTIO:-:rs 
.Among group A patients, those randomised to 
stent implantation had a higher rate of major 
adverse cardiac events than those randomised 
to stopping the procedure (31% v 19%). The 
Breslow-Day test for homogeneity of odds 
ratios between the two patient subgroups was 
sign.ific:mt, showing a higher risk of major 
adverse cardiac events at 12 months of follow 
up in the stentarm (odds ratios 6.603 v 1.197, 
p = 0.046). The CFVR (< 2.5 v > 2.5) before 
second randomisation did not affect IDe long 
term outcome (odds ratios 3.617 v 1.410, 
p = 0.287). 
Discussion 
The main findings of our study are that 
uncomplicated moderate dissections after bal-
loon angioplasty left untreated hud a good long 
term clinical outcome. In agreement with these 
results, several angioplasty studies have 
described a lack of association between the 
Moderate Dissections and Clinical Outcome 
Table 4 Clinical ourwmc at 30 days and 12 months of folLow up in rile group as a whole and in the twO subgroups 
Whokpoup (n=256) Su:ntpoup (n""-124) NofintJ~.Crm:atmmlJ:rOUP (n~JJ2) 
~ Di=;im, Disscaitm 
N~me/rype r,.,c None/type r,xc Noru:ltype r,.,c 
A-B (group (t:M<PA) A-B(.r:rouP "-AJ A-B (group (.r:rouPA) B) (n=111) n=45) p l<atue B) (n=111) (n=13) p Yatue B) (11=100) (n=32) 
,_ 
MACE (30 dnys) 
MACE (12 month) 
TLR (12 month} 
Value~ are o {%). 
5 (5%) 
23 (11%) 
14 (7%) 
3(7%) 
10 (22%) 
8(17%} 
NS 
0.041 
0.016 
2{2%) 
7 (6%) 
3 (3%) 
2 (15%) 
4(31%) 
4(31%) 
0.054 
0.002 
< 0.001 
3(2%) 
16(16%) 
11 (11%) 
1 (3%) 
6(19%) 
•1(13%) '" 
:s-s 
>1S 
MACE, mujor adv=e cuxdiuc cv=m; TLR. target lcrrion r<:WS<.:Ultlrisntion. 
presence of a moderate dissection and the long 
term clinical outcome. »-lo Previous three di-
mensional intracoronary ultrasound dau from 
our group have sho\VD. that the presence of inti-
mal dissection is associated with a greater total 
vessel volume at long term follow up, probably 
owing to favouxable remodelling.'' It is con-
ceivable that the development of a more deeply 
seated injury reduces vessel wall strength, 
thereby predisposing to favourable remodel-
ling. 
Overall, the patients with moderate dissec-
tions had a worse outcome than those with no 
or :mirllmal dissections. This probably refl.ecrs 
the findings in the stented subgroup, which had 
a higher risk of major adverse cardiac events 
than the group with moderate dissections but 
without additional stenting. Although stents 
were placed according to the DEBATE IT pro-
tocol and not to the operator's preference, the 
small s::unple size (n = 13) prevents us from 
drawing any firm conclusions. While coronary 
stenting after the development of moderate 
dissections has proved to reduce the acute 
complication rate, there is no established long 
term clinical benefit of additional stenting in 
patients with uncomplicated moderate dissec-
tion (TIMI 3 flow and absence of signs or 
symptoms of angina). Recent reports have 
shown that coronary stent implantation causes 
more severe injury and a greater infl::unmatory 
response, as well as worse endothelial dysfunc-
tion, than plain balloon angioplasty. :::-t~ It is 
conceivable that the combination of a deep 
arterial injury associated with a moderate 
dissection and the implantation of a metallic 
body may cause a synergistic proliferative 
response. 1" In patients with moderate dissec-
tions, preventing favourable remodelling might 
offset the beneficial stent scaffolding effect. 
The latter could be particularly imponant as 
these patients are a-pected to develop an 
enhanced neointimal response.1" 17 
Our group has previously reported a tempo-
rary reduction in absolute coronary flow 
reserve in patients who developed uncompli-
cated moderate dissections. 1 ~ 'Ibis reflected a 
transient increase in the baseline velocity. 
Therefore the reduced coronary flow reserve 
values did not translate into a greater residual 
stenosis and obstruction of coronary blood 
flow. In the present study, we used the relative 
CFVR~a more reliable index of persistent 
conduit obstruction than the absolute 
CFVR1"-and found similar values between the 
two groups. The latter results indicate that 
without signs or symptoms of ischaemia and 
the presence of 'TIM! 3 flow, no significant 
obstruction to coronary blood flow should be 
a-pected in patients C.'\.-periencing mild to 
moderate dissections. 
Although the use of long or multiple stents 
has recently been reported to be associated 
with a greater restenosis risk, ::a-:::: in our study 
similar lengths and numbers of stents per 
patient were used in the two groups, so this is 
unlikely to be a confounding factor. 
LIMITATIONS 
The limited number of patients with moderate 
dissections prevents us from drav..-in.g definitive 
conclusions. However, tbis is the largest 
prospective study investigating a selected 
population of patients who developed uncom-
plicated moderate dissections and underwent 
randomisation to additional stenting or no fur-
ther treatment, and in whom post-procedural 
Doppler flow data and one year follow up data 
were available. 
CO~CLUSIONS 
Moderate dissections left unstented do not 
have an adverse clinical outcome. Additional 
stenting does not appear to be of benefit. 
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Flow Velocity Acceleration and Restenosis 
Introduction 
Numerous studies have shown that quantitative angiographic assessment after balloon angioplasty (BA) is a 
poor predictor of immediate and long-term outcome 1,2. This limitation of angiography has prompted 
clinicians to use alternative methods for the functional assessment of angioplasty results. After the 
introduction of a Doppler angioplasty guidewire the continuous measurement of blood flow velocity during 
routine angioplasty bas been shown to be clinically usefu13-5. A recent multicentric clinical trial, DEBATE 
I. suggested that a coronary flow velocity reserve greater than 2.5 combined with a residual percentage 
diameter stenosis (DS) lower or equal to 35% after BA predicted a 16% restenosis rate at 6 months follow-
up6. However, the coronary flow velocity reserve is dependent on the status of the coronary microcirculation 
and hemodynamic parameters such as heart rate and blood pressure 7. In addition, a recent study has reported 
a lack of further improvement in coronary flow velocity reserve and maximal adenosine-induced flow 
velocity after additional stent implantation in patients who underwent intracoronary ultrasound-guided BA 
despite substatialluminal gainS. These limitations prompted us to evaluate other Doppler parameters such as 
the maximal stenotic flow velocity (SV) and the presence of stenotic flow velocity acceleration (aSV), both 
dependent on the theory of the continuity equation. The presence of aSV has been reported to be a very 
accurate marker of a significant stenosis 9' 10. Following successful angioplasty, the presence of aSV would 
suggest insufficient luminal enlargement. The purpose of our study was to examine the impact of aSV on the 
long-term angiograpbic results. 
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Methods 
Coronary Doppler flow measurement protocol 
The methods of the DEBATE trial have been previously described 6. In short, 225 patients undergoing 
successful angioplasty of a single lesion were included. Baseline and hyperemic average peak velocities 
measurements were performed proximal and distal to the lesion using a 0.014-incb Doppler tipped 
guidewire. For distal measurements, a distance from the stenosis of at least 5 times the vessel diameter was 
chosen to avoid pre-stenotic acceleration of flow or post-stenotic turbulence, both of which may influence 
local velocities. Following distal measurements, pullback into the lesion site was performed. \Vbencver the 
investigators detected a clinically significant aSV, a thorough documentation of SV measurements was 
attempted. aSV was defined as acceleration in the stenotic coronary flow velocity of 50% or greater 
compared to the baseline velocity assessed at a reference site of the target vessel. According to Caiati et al9, 
acceleration in coronary flow velocity of 50% at the stenotic site is highly sensitive (92%) and specific 
(100%) for diagnosing significant stenosis (diameter stenosis >50%). 
Measurements were performed before and 15 minutes after treatment. The patients were divided into 2 
groups according to the presence or absence of aSV. Any patient with SV measurements complicated by 
technical failure was excluded from the study. 
Balloon Angioplasty and Quantitative Angiographic Measurement 
BA was performed in a conventional manner. At least two cineangiograms, in orthogonal projections, were 
obtained before, after and at 6 months follow-up in the same projections. Intracoronary nitroglycerin (0.1 to 
0.3 mg) or isosorbide dinitrate (1 to 3 mg) was administered to achieve maximal coronary vasodilatation. All 
cinefilrns were sent to an independent core laboratory (Cardialysis. Netherlands), which was blinded to the 
clinical and the Doppler information. Matched views and frames were selected for off-line quantitative 
analysis. A computer-assisted analysis system was used (CAAS ll system, Pie Medical Data). Automatic 
edge detection of the luminal dimensions (m.inimun luminal diameter -lv!LD and reference diameter -RD) 
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were performed by use of the empty guiding catheter as a scaling factor. Restenosis was defined as binary 
angiographic restenosis with a diameter stenosis (DS) >50% at 6 months follow-up. 
Statistics 
Values are reported as means± SD. Comparison between groups was petfonned using paired and unpaired 
Student's t-tests when appropriate. Clinical, angiographic and Doppler-derived variables that had 
demonstrated statistical significant difference among the patients with and without aSV were included in the 
multivariate logistic regression model to identify predictors of angiographic restenosis. A p-value of <0.05 
was considered significant. In search for a diagnostic cut-offvalue ofSV, a receivers operating 
characteristics curve analysis was constructed and the area under the curve is reported which is representative 
of the diagnostic power of the variable cut-offvalue. Sensitivity and specificity, positive and negative 
predictive value of the best cut-offvariable were calculated. 
Results 
Baseline Data and Procedural Results 
From the 225 patients enrolled in the DEBATE I triaL 202 had angiographic follow-up. A total of77/202 patients 
had documented aSV whereas 125 did not experience aSV. From the 77 patients, 23 were excluded from the analysis 
due to technical limitations in the accurate measurement or recording of SV. 
The baseline clinical data offue remaining aSV (n-) and non-aSV (n~ 125) groups is summarized in Table I. 
Patients with aSV were older and had higher proportion of unstable angina than the patients without aSV. (Table I). 
Quantitative Coronary Angiographic and Coronary Flow Velocity Data 
DS, l\1LD and coronary flow velocity reserve values were similar prior to and after balloon angioplasty 
between the 2 groups. (Table II). 
Among the aSV group, 27 patients had measurements performed before, after angioplasty and at 6-month 
follow-up. In those patients, a reduction in SV was seen after angioplasty from 194±74 em/sec to 90±43 
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cmisec (p<O.OOOl), which parallel v.'ith a change in DS from 60±8% to 37±8% (p<O.OOOl). 
No significant linear relationship was observed between the DS and the SV immediately after angioplasty 
while a significant correlation was seen at follow-up. (Figure 1) 
Coronary Flow Velocity Reserve, Stenotic Flow Velocity and Restenosis 
Among the patients with restenosis at 6 month follow~up (n=o=66), the coronary flow velocity reserve was 
similar following the procedure (2.6±0.7 vs. 2.8±1.0, p=O.l77) and lower at follow-up (1.9±0.8 vs. 2.9±0.9) 
when compared to the non-restenotic patients (n===113) (Figure 2). 
Among the aSV group in whom SV was also available at follow-up (n=27), the patients who experienced 
restenosis (n=lS) presented higher SV values following the procedure (107±45 em/sec vs. 68±32 em/sec, 
p=0.025) and at follow-up (169± 27 cmisec vs. 64± 37 em/sec, p<O.OOOl) than non-restenotic patients (n=9, 
Figure 3). Moreover, a significant elevation in SV was observed at follow-up in the restenotic patients (from 
107±45 em/sec to 169± 27 em/sec, JF0.004) whereas no significant change was found in the non-restenotic 
patients (from 68±32 em/sec to 64± 37 em/sec, JF0.707). 
Presence of Stenotic Flow Velocity Acceleration and Restenosis Rate 
At follow-up, the aSV group bad lower MLD and higher DS, late loss and restenosis rate (52% vs. 30%, 
p=0.006) than the group of patients without post-procedural SV acceleration. Among the overall group 
(n=179), the presence of aSV was the strongest independent predictor ofrestenosis (OR 3.08, 95% CI 1.35 to 
7.05, p=0.008). In addition, DS was also an independent predictor ofrestenosis (OR 1.12, 95% CI 1.06 to 
1.18, p<O.OOOl) whereas age, unstable angina., coronary flow velocity reserve were not. 
According to the presence or absence of aSV and a cut-offvalue of35% for post-procedural DS, patients 
were stratified into 4 subsets. Results of this stratification in relation to restenosis are shown in Figure 4. 
Group I, characterized by the presence of aDS '2:: 35% and the presence of aSV, was associated with the 
highest restenosis rate. The most favorable subset of patients is characterized by the absence of aSV and a 
residual DS <35% (Group IV), which was associated with the lowest restenosis rate. The remaining 2 groups 
(II and ill) had an intermediate angiographic outcome. (Figure 4) 
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\Vhen only analyzing the aSV group (n=54), an elevated SV value was the only independent predictor of 
restenosis (OR 1.02~ 95% CI 1.00 tol.032, p=0.034) whereas DS, J\1LD and coronary flow velocity reserve 
were not. 
By receivers operating characteristics curve analysis, the best predictive cut-off value of SV was 101 em/sec 
(area under the curve 66%, 95% CI 0.516 to 0.809, p=0.040). For the patients with SV >101 cmisec (n=l8) 
presented a significantly higher restenosis rate than patients with SV<lOl em/sec (72% vs. 42%, p=0.034). 
In predicting restenosis, a cut-off value of 101 em/sec was associated with a sensitivity of 46%, specificity of 
81%, positive predictive value of 85% and a negative predictive value of 58%. 
Table I. Baseline Characteristics 
Variables 
Age (years) 
F ernale gender 
Diabetes 
Smoking 
Hypercholesterolemia 
Hypertension 
Unstable Angina 
Previous !v11 
Previous BA 
RD before BA (=) 
DS before BA (%) 
aSV 
(N~54) 
62.±8 
11(18) 
8(13) 
11(18) 
27(43) 
19(31) 
42(67) 
5 (9) 
9(14) 
2.96±0.53 
63±9 
N on~aSV p-value 
58±9 0.006 
32(29) NS 
88(8) NS 
31(28) NS 
58( 53) NS 
41(37) NS 
52(47) 0.013 
20 (18) NS 
11(10) NS 
2.82±0.43 0.067 
62±9 NS 
MI: myocardial infarction, RD: reference diameter DS: diameter stenosis, BA: balloon angioplasty 
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Table II. Procedural Data 
aSV 
Variables (N~54) 
BeforeBA 
CVR 1.55± 0.53 
MLD(mm) 1.09±0.30 
AfterBA 
CVR 2.73±0.93 
MLD(mm) 1.84± 0.36 
Follow-up 
CVR 2.30±0.82 
MLD(mm) 1.44±0.49 
Late loss (mm) 0.34±0.39 
Non~aSV 
(N~125) 
1.57±0.63 
1.05±0.27 
2.79±0.92 
1.77±0.34 
2.75±1.07 
1.63±0.49 
0.16±0.42 
p-value 
NS 
NS 
NS 
NS 
0.009 
0.010 
0.003 
BA: balloon angioplasty; :MLD: minimum luminal diameter; CVR: coronary flow velocity reserve, late loss 
is calculated as the difference between the minimal luminal diameter after the intervention and the diameter 
at the six-month follow-up. 
Discussion 
Invasive and non-invasive studies have investigated the feasibility of applying the concept of the continuity 
equation based on Doppler measurements distal and at the stenosis in an attempt to determine the degree of 
coronarj stenosis 9-12_ In agreement vvith these studies, we found 1) a strong correlation between the 
angiographic data and the SV values at 6 months follow-up, 2) higher SV values at follow-up in restcnotic 
compared to non-restenotic patients, 3) a significant reduction in SV values after balloon dilatation whereas 
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the opposite was found at follow-up in patients experiencing restenosis. 
This study is the first describing the relationship between angiographic restenosis and the presence of post-
procedural aSV. As illustrated in figure 4, the predictive value of the aSV appears to be complementary to 
quantitative coronary angiography data. Furthermore, we also found that the higher the SV at the end of the 
intervention, the greater the likelihood of observing restenosis at 6 month follow-up. Based on the continuity 
equation, the presence of high post-procedural SV appears to reflect insufficient luminal gain following the 
intervention, which has been shown to be associated with a greater restenosis risk. 
In the catheterization laboratory, the standard assessment of the arterial conductance is performed by 
measuring the fractional flow reserve (distal coronary pressure divided by aortic pressure at maximal 
hyperemia) 13. A recent study has reported the predictive value of the post-procedural fractional flow reserve 
follov.ring angioplasty14. Since SV is an indicator of the trans-stenotic gradient, it is not surprising to find 
that SV carries a strong predictive value. However, in comparison with pressure measurements, the 
assessment of SV does not require the use of adenosine and is independent on an adequate hyperemic 
response. 
As previously mentioned. the dependency of the coronary flow velocity reserve on the integrity of the 
microcirculation is a major limitation when assessing the post-procedural residual anatomical obstruction. 
Follov.ring angioplasty, SV appears to be exquisitely sensitive to the changes experienced at the treated area 
without depending on the status of the microcirculation. 
Limitations 
The paucity of patients with available SV prevents one from drav.ring definitive conclusions about the value 
of this parameter for the assessment of outcome of percutaneous interventions. 
Due to technical failure, it was not feasible to measure SV in 30% of patients with aSV. This technical 
limitation might be overcome by the on-line automatic detection of the flow velocity contour based on the 
acquisition of the raw Doppler signal and off-line optimal contour detection. These methods are presently 
being prospectively investigated and should prove to be useful for the assessment of these high jet velocities. 
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Clinical implications 
Identification of aSV and the measurement of the SV appear to be useful invasive tools in the assessment of 
angioplasty results and predicting restenosis. Following balloon angioplasty, the presence of aSV alone or in 
conjunction with a SV >than 101 em/sec carries a bad angiograpbic prognosis. justifying adjunctive 
stenting. 
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Figure 1. Relationship between DS and SV at 6-month follow-up 
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Figure 3. SV data in restenotic and non~restenotic patients 
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Flow Velocity Acceleration and Functional Activity 
Value of coronary stenotic flow velocity 
acceleration on the prediction of long-term 
improvement in functional status after angioplasty 
M. Albertal, :MD,a E. Regar, MD,"" J.J. Piek, MD, PhD,h G. Van Langeohove, MD,a S. G. Carlier, MD, a A. Thury, MD,a 
G. Sianos, MD, a E. Boersma, PhD, a B. de Bruyne, MD, PbD,c C. diMarlo, MD, PbD,d andP. W. Serruys, MD, PhD, a 
on behalf of the Doppler Endpoints Balloon AngioplastyTrial Europe (DEBATE) Study Group Rotterdam and 
Amsterdam, The Netherlands, andAalst, Belgium 
Background The coronary flow velocity acceleration at the stenotic site (SVA), defined as a ;?:50% increase in resting 
stenotic velocity when compared with the reference segment, has been shown to be highly sensitive and specific for the 
diagnosis of o hemodynamically significant stenosis. In this study, we describe the value of postprocedurol SVA for the pre-
diction of a lock of improvement in functional activity at long-term follow-up balloon angioplasty [BA). 
Methods We investigated the improvement in functional activity in patients undergoing single native vessel angioplasty 
and intracoronory Doppler [before BA, after BA, and again at 6-month follow-up) as part of the Doppler Endpoints Balloon 
Angioplosty Trial Europe [DEBATE) I trial. Lock of improvement was defined as no change in Duke Activity Status Index 
(DASI) at 6-month follow-up, whereas SVA was defined as ~0% elevation in resting velocity at the treated area compared 
with the distal measurement. 
Results SVA was found more frequently in patients without improvement in DASI [45% vs 31%, P = .03). Similar percent 
diameter stenosis and coronary flow velocity reserve were observed in patients with and those without improvement in DASI 
at follow-up. By multivariate regression analysis, the presence of SVA [P = .029; odds ratio, 1.97; 95% confidence interval, 
1.07 to 3.63) and an elevated DASI at baseline [P < .001; odds ratio, 1.05; 95% confidence interval, 1.03 to 1.07) were 
associated with a lack of improvement at follow-up. 
Conclusions The detection of SVA was associated with failure of improvement in functional activity at follow-up after 
coronary intervention. {Am Heart J 2001 ;142:81-6.) 
The assessment of functional status is the most clini-
cally relevant end point after a percutaneous interven-
tion. However, the factors influencing the functional 
~latus after balloon angioplasty (BA) have not been 
clearly established. Previous studies revealed an asso-
ciation between acute procedural results such as 
diameter stenosis (DS), mini.malluminal diameter 
(MLD), coronary flow velocity rescnre (CFVR). and 
the angiographic outcome at 6-month follow-up.l 
However, the impact of these acute procedural param-
eters on the long-t<.:nn functional ~Latus are unknown. 
A major limitation of the CFVR is its dependency on 
the microvascular status,2 a factor that may lead to an 
underestimation of the acute hemodynamic gain 
obtained after an intervention. Conversely, recent data 
from ~Thoroxcenr<:>r, hAcademi<:e>l Medical Cenk•r, <On:::e Liew Vroo.rw<:> Kliniek, 
Am:okrdam, The Netherland$, and <ICenlro Cuore Co/umbu~, Milan, Italy. 
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have shown that the presence of coronary flow veloc-
ity acceleration at the stenotic site compared with a ref-
erence segment may allow accurate diagnosis of a 
hemodynamically significant ::.teno~is.3,ti We hypothe-
size that the detection of a stenotic flow velocity accel-
eration after angi.oplasty may indicate residual hemody-
namic conduit obstruction, possibly associated with an 
absence of functional status improvement at long-term 
follow-up. 
In this srody, we analyzed the incidence of the post-
procedural stenotic flow velodty acceleration and its 
potential predictive value for the long-term functional 
status. 
Methods 
Patients 
All patientS enrolled in the Doppler EndpointS :&tll.oon 
Angiop~-cy Trial Europe (DEBATE) :.wdy were inYestigated. 
Details of the DEBATE protocol has been pm-iously 
described.1 Briefly, 225 patientS undergoing single native coro-
nary angioplasty and sequential innacoronary Doppler mea-
:.'Ure:lii.entS were enrolled in the DEBATE study. A wta.I of 225 
:md 202 patientS underwent cl.inical and angiogrnphic follow-
up, respectiYely. For our current study, we grouped these 225 
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Table I. Baseline characteristics of the overall population 
Characteristics 
Agc,y 
Female sex 
Diabetes mellitus 
Hypercholesterolemia 
Previous my<><::ardial infarction 
Previous angioplasty 
Smoking 
Excrtionol angina 
Unstable ongino 
Total group 
(n • 225) 
59± 11 
52 (23) 
23(10) 
116[52) 
39(17) 
25[11) 
57[25) 
183[81) 
133[35) 
patients accord.ing to the presence or absence of improve-
ment in functional capacity at long-term follow-up. 
Quantitative coronary angiographic measurements 
and balloon angioplasly 
Balloon angioplasty 'W:lS performed in a convcn:tiona1 man-
ner. At least two cinc:angiogt;llDS, in orthogonal projections, 
were obtained before, after, and at 6-month follow-up in the 
same projections. Intracoronary nitroglycerin (0.1 to 0.3 mg) or 
isosorbide dinitrate (1 to 3 mg) 'W:lS administered to achi(:'\.·e 
maximal coronary vasodilation. All cinc:films were sent to an 
independent core Jabor:Ltory (CardWysis, The Nethc::rlaitds), 
which was blinded to the clinical and the l)Qppler information. 
Matched views and franu:s wen: sdected for off-line quantita-
tive analysis. A computer-assisted analysis system was used 
(CAAS IT system, Pie Medical Data, Maastricht, The Nether-
lands). Automatic edge detection of the hnninai dimensions 
(MLD and rdc:rcnce diameter) v.ras performed with the use of 
the empty guiding catheter as a se:aliog flctor. DS v.ras calor 
lated. Re.1:enosis was defined as binary ang:iographic restc:nosis 
(DS >SO%) at &month follow-up. 
lntracoronary Doppler recording 
Baseline and hyperemic average peak velocity measure-
ments were performed proximal and distal to the lesion 'With 
a O.Dl4-Jnch Doppler tipped guide wire. For distal mem.--ure-
mcnts, a cfu;tance from the stenosis of at least 5 times the ves-
sel diameter was chosen to avoid prestenotic accderation of 
flow or po:,;tstenotic turbulence, both of which may influence 
local velocities. After distal measurements were made, pull-
back into the lesion site was performed. According to Caiati et 
al.~ the observation of coronary flow velocity acceleration of 
~0% at the stenotic site is hlghly se:nsitive (92%) and specific 
(100%) for the diagnosis of a hemodynamlcally significant 
stenosis. Thc:rc:fore, flow velocity acceleration was defined as 
an elev'ation in stenotic coronary flow velocity of~O% com-
pared with distal baseline velocities. Mea~>urements were per-
formed before and 15 minutes after treatment 
Activity assessment 
Ftmctiorull stams was measured in all 225 patients with the 
Duke Activity Status Index (DASI), a 12-item scale with total 
scores ranging from 0 to 58.2 ('with higher scores indicating 
bener functiorull :n::rtus) that evaluates the ability to perform 
common acti"ities of daily living. 5,6 Lack of improvement in 
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DASI was defined as 0% change or reduction in DASI from 
baseline to 6-month follow-up. Angina pecroris was assessed 
according to the Canadian Cardiovascular Society (CCS 1-4) 
and the Braunwald (l-ID, A-B) classification. 
Statistical analysis 
Quantitative data are presented as mean ± SD, whereas qual-
itative dam are presented as frequencies. Continuous variables 
were compared by means of an unpaired Student t te>1. Cate-
goric variables were compared by means of Fisher exact test. 
Stepwise logistic regression was performed to search for inde-
pendent predictors of a lack of improvement in functional ~u­
tus at follow-up. A v:alue of P < .05 was considered statistically 
significant. 
Results 
Baseline and procedural data of the study 
population 
Two-hundred rwenry~fivc patients were enrolled. 
Table I illustrates the baseline characteristics of the 
study population. After BA. the DS decreased from 62% 
± ~Ai (MLD, 1.06 ± 0.27 rum) to 37% ± 8% (MLD, 1.79 ± 
0.34 rnm; P < .001), whereas the CFVR increased from 
1.58 ± 0.60 to 2.72 ± 0.91 (P < .001). 
In 82 (37%) patients, the presence of coronary flow 
velocity acceleration of~O% at the lesion site was 
detected. 
Functional status at baseline and follow-up 
At !-month follow-up, the DASI increased from 18 ± 
14to 24 ± 15 (P< .OOI)aod to 23 ± 18 (P< .001 vs 
before BA) at 6-month follow-up. The functional status 
of all the patients in the study, as assessed by the DASI, 
increased by 6.75 units (85%, P < .0001) at early follow-
up. From baseline to 6-month follow-up, the DASI 
increased by 5.0 units (58%, P < .001), whereas no sig-
nificant changes in functional status score were seen 
between early and late follow-up. 
Sequential DASI and the presence of angina symp-
toms (before angiop~"tf and at 1- and 6-month follow· 
up) as well as Doppler and quantitative coronary 
angiography (QCA) measurements (baseline, immedi-
ately after angioplasty, and at 6-month follow-up) are 
shown in Figure 1. 
Failure of functional status improvement ot long~ 
term follow~up 
From the overall population, 129 (56%) patients had 
an improved DASI at 6-month follow-up. whereas 96 
(44%) patients did noL Furthermore, similar risk factor 
profile (age, sex, diabetes mellitus, hypertension, 
hypercholesterolemia, smoking, history of a previous 
angioplasty) was found among the 2 subgroups. 
The improvement group had a greater proportion of 
patients with baseline cxcrtional angina compared with 
the nonimprovement group (87% vs 76%, P = .030). 
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DASI and CFVR in improvement and nonimprovement groups. 
Figure 2 illustrates the DASI values at baseline and at l-
and 6-month follow-up of both subgroups. The 
improvement group had a lower baseline DASI than did 
the nooimprovcmcnt group (Figure 2). 
QCA and Doppler-derived data of patients with 
and those without improvement in functional status 
at follow-up 
Angiogcaphic data of both subgroups arc shown in 
Table II. At follow~up. a greater .MLD and a lower DS 
were found in the improvement group compared with 
the nonimprovement group (Table II), whereas base~ 
line and postprocedural DS and MID wc:rc found to be 
similar in both subgroups. 
CFVR was similar in both groups before BA, after 
BA, and at 6-month follow~up (Figure 2). However, 
postprocedural stenotic flow velocity acceleration 
was detected more frequently in the nonimprovc-
ment group than in the improvement group (P = 
.033, Figure 3). 
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Figure 3 
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Predictors of DASI at long-term follow-up 
By univariate analysis, the absence of exertional 
angina and an clC\'ated DASI at baseline assessment in 
addition to the presence of flow velocity acceleration at 
the ballooned site were associated with a lack of 
improvement in functional status at long-term follow-up 
(fable III). Age, sex, hypertension, hypercholes-
terolemia., diabetes mellirus, and previous myocardial 
infarction were not independent predictors of a lack of 
improvement in functional status at follow-up. 
Multivariate logistic regression analysis revealed that 
an elevated baseline DASI and the presence of stenosis 
flow velocity acceleration were the only independent 
predictors of a lack of improvement in functional ~ttatus 
at long-term follow-up (fable Ill). 
After excluding all rcstcnotic patients (n = 72), the 
presence of baseline exertional angina (odds ratio, 0.24; 
95% confidence interval, 0.62 to 0.96; P = .003) was 
retained as the ooly predictor of no improvement in 
functional status at long-term follow-up. 
Discussion 
From this study, several findings should be men-
tioned: (1) the detection of postprocedural stenotic 
flow velocity acceleration predicted a lack of improve-
ment in functional status at long-term follow-up; (2) 
~tandard QCA and Doppler flow measurements failed to 
predict the long-term changes in functional !:>Latus. 
Several studies including DEBATE I have described 
the predictive value of postproeedu.ral QCA data for the 
prediction of angiographie tc!:>1COosis.1,7-9 Despite the 
latter, postprocedural QCA data did not predict the 
functional status at long-term follow-up. Reports from 
our group and others have shown that QCA is not accu-
rate for evaluating the degree of re.idual hemodynamic 
obstruction after an intervention. 2·10.12 Furthermore, in 
concert with previous studies, 13-15 we obSCl"'led that ooly 
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Table 11. QCAdoto of patients with ond those without func-
tional improvement at 6-rnonth follow-up 
Reference diameter (mm} 
DS before BA (%} 
MLD before BA (mm} 
DS after BA (%} 
MLD ofter BA (mm} 
DSat6 mo (%) 
MLD at 6 mo (mm) 
Improve- No 
ment improvement P 
{n = 129) {n = 96) value 
2.84±0.51 
62±9 
1.07 ± 0.30 
37±9 
1.79 ± 0.35 
42± 15 
1.63 ± 0.49 
2.86 ± 0.45 
63±8 
1.05 ± 0.26 
38± 8 
1.78 ± 0.32 
48± 16 
1.44±0.49 
NS 
NS 
NS 
NS 
NS 
.007 
.010 
62% (a= 43) of the restcnotic patients had symptoms of 
angina at 6-month follow-up. It is conceivable that post-
procedural QCA data might ooly predict the long-term 
morphologic changes obsenred at the ballooned site irre-
spective of its hemodynamic ~ignificance. In contrast, 
the detection of stenotic flow velocity acceleration indi-
cates the presence of a more ph)'!:>iologically significant 
residual obstruction, which may also predict significant 
physiologic changes observed in the epicardial lumen at 
long-term follow-up. 
Several reports have described the dependency of 
CFVR on the microcirculation.16-I9 The latter is particu-
larly important in patients with diabetes, 20 left ventricu-
lar hypcrtrophy,21 or pfC'iious myocardial i.nfurction,22·25 
in whom an inability to mount an adequate hyperemic 
response could re:rult in an underestimation of the 
actual epicardial luminal gain after a percutaneous 
intervention. In addition, a transient elevation in base-
line velocities caused by a delay in the recovery of 
microvascular autoregulation, 18 post occlusive hyper-
emic response, or intracoronary nitrates may also trans-
late into a low CFVR. Surprisingly, the improvement in 
functional status was not followed by a higher CFVR at 
6-month follow-up. This uno..'Pccted finding further 
:mpports the concept that the absolute CFVR is a rather 
nonspecific anatomic index subjected to sc:.·vere inher-
ent limitations. 
Our study is the first one demonstrating the value of 
flow velocity acceleration at the ballooned site for the 
prediction of an improvement in functional status at 6-
month follow-up. The presence of coronary flow veloc-
ity acceleration at the end of the procedure may indi-
cate a hemodynamically !:>ignificant residual stenosis, 
possibly CX'Plaining its strong predictive value. This 
new invasive index presents several advantages. First. it 
is independent of hemodynamic variables. Second, it 
docs not require an adequate hyperemic response. 
Third, it may convey specific information regarding 
arterial conductance.3,26,27 
From the cUtTCOt study, whenever stenotic velocity 
acceleration is being identified, it appears jm."tified to 
Flow Velocity Acceleration and Functional Activity 
Table III. Univariate and multivariate predictors of lock of improvement in functional status at long-term follow-up 
Variables 
Exertionol angina 
Baseline DASI 
Sl/ occclerotion 
Univariate 
Pvalue(OR..95%CI) 
.045 (0.46, 0.22-0.94) 
<.001 (1.05, 1.02-1.07) 
0.033 
OR, Odds ratio; C/, c:onBdMcc intervai; SV, Row veloci!y at th" skmo.is site. 
undergo additional anatomic evaluation in an attempt 
to rule out residual conduit obstruction and to improve 
the long-term functional status. 
Limitations 
In our study, we used Doppler<lerivcd parameters to 
assess the ph~iologic changes occurring after balloon 
dilatation. In patients with postprocedural flow accelera-
tion, the use of transstenotic guide wire pressure<lerivcd 
fractional flow reserve could have helped us verify the 
presence of a significant ro.idual conduit obstruction. 28 
However, in contrast with the asse&.mcnt of flow veloc-
ity acceleration, fractional flow reserve is dependent on 
an adequate hyperemic response. 
In our study, we did not ffiCJ!.llre the relative CFVR 
(the ratio of target vessel CFVR to the CFVR in a normal 
reference vessel). This indc."( has been advocated for 
the objective evidence of the functional lesion severity 
because it is relatively independent of hemodynamic 
variables.29.30 Howcver1 it is concei\o'ablc that alter-
ations in baseline and/or hyperemic velocities immedi· 
ately after the procedure may also confound the rela-
tive CFVR results. Furthermore, its role in the 
evaluation of the hemodynamic changes occurring after 
a percutaneous intervention is still undefined 
Stenotic flow velocity accelcration at the end of the 
angioplasty procedure predicted a failure to improve 
long-term functional status. The possible impact on 
thctapeutic strategies, however, has not been an objec-
tive of this study. Further investigations arc needed to 
elucidate the value of this parameter in guidance of 
angioplasty procedures such as provisional stcnting. 
Conclusions 
Stenotic flow velocity acceleration at the end of the 
angioplasry procedure predicted a failure to improve 
the functional status at 6-month follow-up. 
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High Shear Stress and Restenosis 
Introduction 
Vascular wall shear stress (WSS), the frictional force exerted by the flowing blood on the 
endothelium of the artery, has repeatedly been implied in the pathogenesis of atherosclerosis 
and vascular remodeling (1-6). The pathophysiologic mechanisms linking these events are 
diverse. Abnormal shear stress induces pathways that transmit information to the cell nucleus, 
where expression of certain genes may occur. The actions initiated by these genes can-
amongst others - result in cellular adhesion onto the vascular wall, lipid accumulation, release 
of vasoactive substances, induction of growth factors and interference with smooth muscle 
cell proliferatory characteristics (7-18). It has not unequivocally been shown whether rapid 
changes in shear stress, gradients in shear stress or low, oscillatory shear stress is the main 
modulator of atherogenesis, although recent evidence points to the latter (19-21). 
Although, there is strong scientific evidence that WSS is a key player in the pathophysiology 
of atherosclerosis (3, 20-21 ), no evidence for its role in restenosis after balloon angioplasty 
has been provided. Also, no currently available technique can measure local wall shear stress 
in vivo on-line. Recently, our group developed a two-step off-line apparatus to assess WSS at 
numerous finite elements of the luminal surface, combining the newly developed ANGUS 
(combination of ANGiography and intravascular UltraSound) method (22) with 3-
dimensional computational fluid dynamics (23-25). This method, however, remains time 
consuming, and cannot be used on-line in the catheterization laboratory to evaluate the 
possible necessity for adjunctive treatment after balloon angioplasty. 
Balloon angioplasty is subjected to an undesirable rate ofrestenosis (26). Prediction of 
restenosis is conventionally based on consideration of patient characteristics, the targeted 
lesion and post-procedural angiographic parameters. Although functional parameters such as 
post-procedural Doppler-derived coronary flow velocity reserve (CFR) or fractional flow 
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reserve obtained by a sensor tipped guidewire further extend the performance of quantitative 
coronary angiography (QCA) in predicting restenosis after PTCA (27-29), the functional 
parameter with optimal predictive accuracy is still sought. 
However, average WSS may be calculated in vivo for an entire cross-sectional segment of 
arteries from the known lumen radius and volume flow rate using the Hagen-Poiseuille 
equation (30-31). Volumetric blood flow can be estimated at that site of the vessel by 
multiplying Doppler-derived average peak velocity (APV) with cross sectional area (CSA) 
assessed by QCA (32,33). 
We aimed to introduce the concept of calculation of this average WSS to the clinical setting 
and to establish the possible predictive value of post-procedural WSS parameters on 
restenosis, target lesion revascularization (TLR) rate and the reoccurrence of angina and/or 
positive exercise stress testing after angiographically successful balloon angioplasty. 
Methods 
Patient selection 
Methods of the DEBATE I trial have been described in detail previously (27). In short, 297 
patients undergoing successful balloon angioplasty of a single lesion were included. Baseline 
and hyperemic flow velocity measurements were performed proximal and distal to the lesion 
and at the site of the lesion using a 0.014-inch Doppler tipped guidewire (Flo Wire, 
Endosonics Co., Rancho Cordova, CA, USA). For both proximal and distal measurements, a 
distance from the stenosis of at least 5 times the vessel diameter was chosen to avoid 
prestenotic acceleration of flow or poststenotic turbulence, both of which may influence local 
velocity. This, in turn, would affect the laminar flow conditions, which is an essential 
assumption for flow and WSS calculations. The site of the blood flow velocity measurements 
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was recorded on cinefihn, providing to obtain flow recording in the same position at post~ 
procedure and follow-up. The Doppler data were not used as guidance for the intervention; 
only angiographic criteria (diameter stenosis [DS] <50% in any angiographic view) were used 
to determine the end point (successfulness) of the angioplasty procedure. For various reasons 
as bailout stenting and urgent revascularization, 225 patients were finally enrolled and 202 
had a 6-month control coronary angiogram performed, again with the Doppler measurements 
made at the different sites. The population of these 202 patients formed the subject of our 
study. 
Calculation of wall shear stress 
WSS was computed proximal and distal to the lesion and in the lesion, before and after 
treatment and at 6-month repeat angiogram using the Hagen-Poiseuille formula (30): 
WSS=4~Q/rrR3, with~ being blood viscosity, taken to be constant at 0.03 Poise (~0.003 
Ns/m2), Q the volumetric blood flow in ml/sec, and R the radius of the coronary lumen at the 
site of the flow measurement. Volumetric flow was calculated from blood velocity (asswning 
parabolic flow) measured with intravascular Doppler using the validated formula (32,33): 
Q~CSA x APV x 0.5, where CSA is the cross-sectional area and APV is the baseline (before 
adenosine administration) average peak velocity. Minimal and reference vessel CSA was 
measured by videodensitometry with a computer-assisted quantitative coronary angiography 
analysis system (CAAS II system, Pie Medical Data, Maastricht, The Netherlands). Lumen 
radius to apply the Hagen-Poiseuille formula was derived from videodensitometric area 
(R ~ .JCSA!tt) in order to achieve the best approximation of the real lumen dimension (34). 
In-lesion WSS values (WSSin-lcsion) were calculated with minimal CSA and the in-lesion 
velocities, whereas proximal (WSSprox) and distal to the lesion values (WSSmst) were derived 
from the measured APV at those sites and the reference segment CSA. After replacing the 
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constants and substituting the equations the fmal formula used for each calculation was: 
WSS~O.l 0635 x APV ;.J CSA , and results were expressed in N/m2 
Follow-up and study endpoints 
Quantitative angiography was repeated at the 6-month follow-up visit. Angiographic 
restenosis was defined as aDS >50% on the follow-up angiogram. The rate for target lesion 
revascularization (TLR) was determined based on the presence of angiographic restenosis of 
the remote angioplasty site in a patient with either symptoms or signs of ischemia. The 
anginal status of the patients was evaluated and, when possible, a symptom-limited bicycle 
stress test was performed at the 1 month and at 6 months follow-up visits. 
Statistical analysis 
Values are reported as means± SD. Analyses were accomplished applying a standard 
software package (SPSS 9.0, SPSS Inc. Chicago, IL, USA). Comparison between groups of 
patients in respect to the presence ofrestenosis was evaluated by unpaired Student's t~tests. 
Differences within WSS values after the procedure and at follow-up were evaluated by paired 
Student's t-tests. Univariate and multivariate logistic regression tests were performed to study 
the diagnostic value ofWSS data and other variables to predict angiographic and clinical 
endpoints. Receiver operator characteristic curve (ROC) analyses were performed to find the 
optimal (where sensitivity equals specificity) cut-off value of variables. 
Results 
Comparison of angiographic and Doppler flow measurements 
The baseline characteristics of study patients, the procedural and clinical outcomes are 
detailed elsewhere (27). Seventy-two patients presented with angiographical restenosis at 
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follow-up and 62 had reintervention during the study period. After the successful initial 
intervention, distal velocity measurements were obtained in all, at proximal site in 183 and at 
the site of the minimal lumen diameter with acceptable quality in 56 patients. At follow-up 
cardiac catheterization distal measurements were taken in 182, at the lesion site in 7 4 and in 
173 vessels proximal to the remote target site. Results ofvideodensitometric QCA analysis 
and Doppler study at post-procedure and their comparison in respect to restenosis are given in 
Table 1. Post-procedural residual minimal CSA, the reference segment CSA and percent area 
stenosis did not differ between the groups. The APV in-lesion tended to be higher in 
restenotic lesions than in non-restenotic lesions. The difference was small but significant at 
the site proximal to the lesion. 
Comparison of different WSS values 
Table 2 gives the calculated WSS values at pre-, post-procedure and at follow-up at the 
different locations and their comparison beween restenotic and non-restenotic patients. It is 
seen that the post-procedural WSSprox and WSSin~lcsion, and WSSm-lesion at follow-up are 
significantly higher in the group with versus the group without restenosis. Figure 1 shows the 
results of the paired t-tests performed to compare post-procedural and follow-up WSS values 
and reveals significant change in the restenosis group (Fig. l[a]) at the in-lesion location; it 
increases at follow-up; reflecting the recurrence of lumen obstruction. WSSprox and WSSdist 
remain in narrow range (0.6-1.4 N/m2). 
Predictive values of WSS measurements on angiographic restenosis and TLR 
Bivariate logistic regressions and ROC-curves were applied to establish the prognostic power 
of post-procedural respective values ofWSS to predict the recurrence ofrestenosis (Table 3) 
and TLR (Table 4). WSSm.Jesion had a good predictive value for angiographic restenosis (ROC 
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area, 66%, P<O.OS, Figure 2). The ROC analysis detected an optimal cut-off value of2.58 
N/m2 above which restenosis could be predicted with a sensitivity and specificity of 62%. 
WSSpro,had a reasonable (ROC area, 62%, P<O.OI), WSSd;.,, had a modest (ROC area, 60%, 
P<O.OS) power to predict TLR. On the other hand, as it is depicted in Table 4, the measured 
APV at the corresponding reference segments also had a prognostic value for TLR (ROC 
area, 61%, P<O.OS for the proximal and ROC area 59%, P<O.OS for the distal site). 
In order to assess any additional independent predictive value ofWSS parameters, the results 
of post-procedural DS and distal CFR measurements as known independent predictors for 
worse outcome after BA (27) were entered in the multivariate analysis (Table 5). In predicting 
restenosis DS proved to be an independent predictor (OR~ 1.10, P<O.OO!), when added to the 
respective values ofWSS at the reference segments and distal CFR. However, WSSprox was 
the ouly independent predictor for TLR (OR~ 2.15, P<0.05). 
Predictive values ofWSS measurements on early and late recurrence of symptoms 
and/or ischemia 
The relations between the post-procedural APV, CSA, calculated WSS parameters and the 
reoccurrence of angina and/or ischemia at 1 and 6 months follow-up were also analyzed. 
None of the variables had significant predictive power in respect to the 1-month results (data 
not shown). For predicting late recurrence of symptoms and/or ischemia only WSSprox 
revealed significant prognostic value (ROC area, 62%, P<0.05). However, in the multivariate 
model it did not prove to be an independent predictor. 
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Table 1. Comparison ofvideodensitometric cross-sectional areas, area stenosis and average 
peak velocities of vessels measured at post~procedure in respect to binary restenosis at 6-
month follow-up. 
RESTENOSIS NO RESTENOSIS p 
CSA""" (mm") 3.2 ± 1.3 (72) 3.5 ± 1.5 (130) 0.105 
CSA"r (mm") 6.6 ± 1.8 (72) 6.6 ± 2.3 (130) 0.996 
AS(%)* 51.8 ± 13.1 (72) 45.6 ± 15.0 (130) 0.107 
APVpcox(cm/s) 28.9 ± 14.2 ( 66) 24.6 ± 11.4 (117) 0.036 
APVin·lesion ( cm/s) 53.6 ± 27.9 (29) 42.4 ± 18.9 (27) 0.089 
APVdist:~J(cm/s) 18.1 ± 6.8 (72) 17.4±8.8 (130) 0.505 
* Residual diameter stenosis measured with edge detection was <50% for both groups. 
CSAmin = minimal cross-sectional area, CSAref = reference segment cross-sectional area, AS = 
percent area stenosis, APV prox, APV in-lesion and APV distal = average peak velocity at proximal 
to, at the site of and distal to the targeted lesion. 
Values are mean± SD. Numbers in parentheses indicate the available number of observations. 
Statistically significant values are in bold. 
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Table 2. Calculated WSS values at different sites at pre-, post-procedure and at follow-up in 
respect to binary restenosis at 6-month follow-up. 
RESTENOSIS NO RESTENOSIS p 
"' ~ 
WSSprox 0.97 ± 0.46 (64) 0.89 ± 0.46 (116) 0.225 
p 
.:, ~ WSS;u~lesion 16.06 ± 10.3 (17) 10.97 ± 9.2 (33) 0.097 
~ 
"' ... u 0 wssdist:LI 0.70 ± 0.36 (71) 0.65 ± 0.32 (127) 0.319 ~ 
... 
~ WSSprox 1.22 ± 0.61 (66) 1.05 ± 0.51 (117) 0.047 
,.:, p ~ WSSiu-lcsion 3.61 ± 2.38 (29) 2.46 ± 1.39 (27) 0.033 (IJ 
"' 
0 u 
... 0 
~ wssdist:d 0.78 ± 0.34 (72) 0.76 ± 0.45 (130) 0.660 
... 
... p 
WSSprox 1.06 ± 0.70 (60) 1.06 ± 0.80 (113) 0.973 
' ~ WSSrn~lesion 10.51 ± 8.84 (35) 3.03 ± 2.05 (39) 0.000 0 
....l 
....l 
wssdistnl 0.77 ± 0.53 (61) 0.76 ± 0.37 (121) 0.863 0 
... 
WSSprox = wall shear stress proximal to the lesion, WSSin-lesion =wall shear stress in the 
lesion, WSSrust = wall shear stress distal to the lesion. 
Values are mean± SD and expressed in N/m2 • Numbers in parentheses indicate the available 
number of observations. Statistically significant values are in bold. 
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Table 3. Predictive values of post-procedural WSS, APV and CSA for restenosis at 6 months 
follow-up. Results of ROC curve analysis and univariate logistic regression tests. 
ROC Area P-value of the Univariate regression 
Variable Cut-off 
(95% CI) ROC curve OR p 
wss,,,, (183) 0.97 58 (49-66) 0.085 1.72 0.051 
APV ''"' (203) 24.3 59 (50-68) 0.051 1.03 0.030 
WSSin-lesion (56) 2.58 66 (51-80) 0.048 1.42 0.048 
APVtn-lesion (56) 41.0 61 (46-76) 0.156 1.02 0.100 
wssdi"'"' (202) 0.69 55 (52-69) 0.216 1.16 0.664 
APV ,1,,.1 (225) 16.0 57 (49-65) 0.118 1.01 0.540 
CSAm;, (202) 3.15 56 (48-64) 0.165 0.84 0.119 
CSA,r(202) 6.45 53 (44-61) 0.530 1.00 0.996 
ROC =receiver operator characteristic, CI = confidence interval, OR= odds ratio. 
Numbers in parentheses indicate the available number of observations. Statistically significant 
values are in bold. 
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Table 4. Predictive values of post-procedural WSS, APV and CSA for target lesion 
revascularization rate during 6 months follow-up. Results of ROC curve analysis and 
univariate logistic regression tests. 
ROC Area P-value of the Univariate regression 
Variable Cut-off 
(95% CI) ROC curve OR p 
wss,,., (183) 1.00 62 (53-71) 0.008 2.33 0.004 
APV ''"' (203) 24.6 61 (52-70) 0.013 1.04 0.003 
WSSin·lcsion (56) 2.70 58 (42-74) 0.324 1.19 0.226 
APVin·lesion (56) 40.4 58 (41-75) 0.305 1.02 0.115 
WSS'""'' (202) 0.71 60 (51-69) 0.026 1.90 0.088 
APV "'"" (225) 16.5 59 (50-67) 0.043 1.03 0.140 
CSAmm(202) 3.14 56 (48-65) 0.156 0.84 0.139 
CSArer (202) 6.20 46 (37-55) 0.392 1.00 0.506 
ROC =receiver operator characteristic, CI =confidence intexval, OR= odds ratio. 
Numbers in parentheses indicate the available number of observations. Statistically significant 
values are in bold. 
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Table 5. Results of multivariate logistic regression ofCFR and post-procedural DS with 
respective WSS values for prediction of restenosis and target lesion revascularization. 
Restenosis Target lesion revascularization 
OR CI P-value OR CI P-value 
WSSprox !.82 0.98-3.37 0.055 2_15 1.17-3.95 0.014 
CFR 0.93 0.63-1.35 0.690 0.80 0.54-1.19 0.270 
DS(%) 1.10 1.04-1.13 0.000 1.03 0.99-1.08 0.104 
wssin-lcsion !.33 0.91-1.95 0.140 1.17 0.85-1.62 0.34 
CFR 0.96 0.49-1.88 0.910 0.70 0.35-1.41 0.32 
DS(%) !.05 0.97-1.14 0.250 0.97 0.89-1.05 0.45 
WSSdisui !.24 0.56-2.76 0.59 !.56 0.78-3.50 0.276 
CFR 0.84 0.57-1.23 0.370 0.71 0.48-1.07 0.103 
DS(%) 1.09 1.05-1.14 0.000 1.04 0.99-1.08 0.066 
CFR = distal coronary flow reserve, DS = diameter stenosis, OR= odds ratio, CI = 95% 
confidence intervaL 
Significant values are in bold. 
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Discussion 
The main findings of the current study are: (1) Higher WSS values measured in-lesion 
(WSSin-lesion) immediately after balloon angioplasty are predictive for restenosis. (2) TLR is 
predicted by WSSP"' and WSSd;,. (3) Moreover, after adding known independent predictors 
such as DS and distal CFR, WSSp,, remained the only independent predictor for TLR. These 
results suggest that the post-balloon angioplasty higher wall shear stress is associated with 
increased probability of restenosis and/or TLR during the follow-up period. Thus, it is 
conceivable that WSS, indeed, might contribute to the restenotic process. The method 
described allow one to calculate on-line the average value ofWSS for a particular segment of 
the coronary artery after angioplasty. This is the first study to report the potential prognostic 
value of a combined functional and morphologic parameter for the outcome after BA, which 
does not necessitate administering a provocative agent. 
Although some authors put forward the involvement ofWSS in the restenosis 
pathophysiology (35), there is lack of scientific evidence in humans. High shear forces have 
been shov.rn to induce thrombus formation (36-39), which in turn, through local platelet 
deposition with the subsequent release of chemotactic and mitogenic factors, such as platelet-
derived growth factor and thrombin, may induce restenosis ( 40). Chow et al. showed that 
pathological levels ofWSS (>3 N/m') initiate platelet aggregation (41). Thus, the induction of 
localized thrombus formation may be the initiating factor for restenosis in our patients. 
However, higher WSS at post-procedure was not associated with an increase of early 
recurrence of anginal complaints or exercise-induced ischemia. Cyclic flow variation may be 
a warning sign for immediate thrombotic vessel closure after angioplasty ( 42). To examine 
the possible relation bet\Veen this phenomenon and the corresponding acute changes in WSS 
was beyond the scope of the present study. 
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Although. high average shear stress values for the entire cross-section were calculated in our 
patient group, no certainty about the spatial distribution of the WSS could be investigated. 
Indeed, it is possible that next to a high average WSS; regions of low shear stress exist. As 
previously shown, zones of low WSS can also coexist with flow separation zones inducing 
strong secondary flows ( 43). It might be that especially these regions are prone to the 
evolvement ofrestenosis: possibly the patients that developed restenosis had more severe 
vessel injury after PTCA, with more flow separation and more regions of secondary flow and 
localized slow flow, facts not accounted for by the present angiographic and Doppler 
evaluation. One might also speculate that turbulent flow across residual stenosis results in low 
shear stress downstream at the distal site of the lesion (not the site of the distal flow velocity 
measurement), known to be a preferential part for smooth muscle cell proliferation (44). 
Moreover, the higher WSS values after the procedure in the restenosis group might be 
explained by an increased baseline flow after the procedure and/or a less optimal angioplasty 
result with a lower residual CSA. However, APVin-Jcsion and CSAmin after the procedure did not 
differ significantly between the two groups. Furthermore, these parameters alone, which were 
taken for the WSS calculation, did not appear to have any predictive power. 
Shear stress values in the arteries tend to attain a baseline value, which seems to be constant 
throughout the whole arterial vascular tree. Kamiya et al. found this value to be around 1.5 
N/m2 ( 45). This is in part confirmed by our study, which shows WSS values in the non-
diseased parts of the vessels to be between 0.6-1.4 N/m2. The WSS values found in the lesion 
seem unreasonably high (up to 20 N/m2); however Strony eta!. showed that WSS could be as 
high as 100 N/m2 in severely atherosclerotic arteries ( 46). 
The influence of the higher WSS of the proximal reference segments on late anginal 
symptoms and TLR is difficult to interpret. But the mechanisms through which WSS exerts 
its effect are extremely diverse and a substantial interplay between adjacent segments of the 
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artery might exist. The mechanical signal provided by laminar shear stress is transmitted to 
the cellular nuclei, with the induction of certain genes or inhibition of expression of other 
genes, thereby inducing different pathogenetic events such as the suppression of platelet-
derived growth factor (PDGF), monocyte adhesion on the endothelium and influence on the 
growth process of the endothelial cells (47-49). These molecular events might act not ouly the 
treated site of the vessel but also from a certain distance. 
Our results are promising, viewing the current strategy of "stent-like balloon angioplasty", 
which reduces the rate ofrestenosis (50). Recent data (51) showed that outcome after 
"provisional stenting" (guided by distal CFR results upon QCA) is comparable to systematic 
stenting. Application ofWSS measurement may eliminate the necessity to administer a 
vasodilatory agent to measure flow reserve. It appears that having normal values ofWSSin-
Jesion and WSSprox might be translated as good functional and angiographic result after balloon 
dilatation and are associated with less restenosis and TLR. Thus, unnecessary adjunctive 
therapy (e.g. stent implantation) after a successful balloon angioplasty might be avoided with 
the use of these parameters. Only a large, prospective study may clarify the potential of this 
strategy in comparison with systematic stenting. 
Limitations 
Important limitations to our study and its findings should be mentioned. The present 
calculations of shear stress assumes that blood is an incompressible, homogeneous Newtonian 
fluid at constant temperature, that the coronary arteries are rigid and that the flow is laminar 
and in steady state (30). In addition, the Hagen-Poiseuille formula (WSS=4flQhtR3) yields 
accurate results for a fully developed Poiseuille flow and for an idealized cylindrical stenosis. 
All these assumptions may be questioned in a coronary artery following balloon angioplasty, 
with the creation of an irregular vessel wall profile, possible disturbance in blood viscosity 
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due to clotting factors, and the disappearance of an intact endothelium. It might also be 
possible that the actual area of flow is different than what the densitometric CSA provided to 
derive the lumen radius for the Hagen-Poiseuille formula, thus resulting in incorrect values. 
However, it has been shov.rn that videodensitometric quantitative angiography offers a better 
correlation to true luminal dimensions after BA or directional coronary atherectomy than edge 
detection, using intracoronary ultrasound as the gold standard (52, 53). 
Furthermore, it cannot be ascertained that the measurements made using a Doppler wire are 
really accurate (for instance, that the wire was placed in the region of optimal flow after 
balloon angioplasty), and that the wire itself has no influence on the flow it is measuring, as 
previously suggested by Back (54). Indeed, flow-measuring techniques perform best when the 
flow profile is well establishe<L and the tube is straight. In vivo, however, there are curves, 
bifurcations, luminal enlargements and narrowings, and atheromatous plaques causing flow 
disturbances and turbulence (43). 
Finally, some concern may arise as to the value of these average shear stress measurements. 
Although heterogeneous responses of neighboring endothelial cells to WSS and high local 
variations in WSS have been described (55), Zarins et al. showed that average macroscopic 
shear stress values can be accurately derived from vessel geometry and flow parameters 
(56,57). 
Conclusion 
Our study shows that high average WSS after balloon angioplasty might be detrimental in 
terms of angiographic and functional outcome. WSS, as a combined parameter of anatomy 
and physiology can be used for the on-line assessment of procedural result in the 
catheterization laboratory without the need of a provocative agent. Further prospective studies 
may further assess the prognostic value of this new parameter. 
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Figure. 
Receiver operative characteristics curve showing the best in-lesion post-procedural wall 
shear stress cut-off value (2.58 N/m2 ) for the presence ofrestenosis. 
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SUMMARY AND CONCLUSION 

Summary and Conclusion 
The absolute coronary flow velocity reserve, the ratio of hyperemic to basal mean flow 
velocity, has been used at the cardiac catheterisation for clinical-decision making and for 
a further understanding of the pathophysiology processes involved in diseases such as 
variant angina, syndrome X, left ventricular hypertrophy, hypertension, diabetes and 
acute coronary syndromes. 
This index is dependent on the patency of the epicardial conduit and the status of the 
microvascular circulation. In the absence of epicardial conduit obstruction, the CVR may 
be abnormal only on the basis of a compromised microcirculation. Therefore, an 
abnormal CVR cannot differentiate which of the 2 components is responsible for flow 
impairment. For example, utilizing the DEBATE database, which collected sequential 
Doppler-derived data (before, after and at 6-month follow-up angioplasty), we were only 
able to observe a transient impairment in hyperemic velocity in patients with an impaired 
CFVR. The hyperemic improvement observed in those patients at follow-up was 
unrelated to geometrical changes experienced at the lesion site. Furthermore, in patients 
undergoing balloon angioplasty and additional stenting as part of the DEBATE II trial, 
we further dissected the causes of depressed hyperaemic flow velocity in two: 1) 
Insufficient luminal enlargement after angioplasty 2) Persistent microvascular 
dysfunction following adequate stent deployment (Chapter III). 
Another caveat encountered when utilizing the post-procedural absolute CFVR is that 
inappropriate elevations of the resting average peak velocity would falsely diminish the 
161 
Chapter 70 
actual CFVR value. Several authors have previously reported elevations in resting flow 
velocities as the main cause of an impaired CFVR. These reports only described transient 
elevations, which could be explained by a delay in the coronary autoregulation. In 
addition, in-vitro and in-vivo studies have directed the attention to coronary 
miocroembolization as a cause for transient elevations of the resting blood flow following 
percutaneous interventions. This response appears to be mediated by adenosine release 
from microvessels at the microembolized territories. In chapter II, we reported our results 
from Debate I database showing higher resting blood flow velocities prior to, after and at 
6-month follow-up balloon angioplasty in patients with an impaired CFVR when 
compared to controls. Moreover, we also report an elevation in resting velocity not only 
in the target but also at the reference vessel (Chapter III). Therefore, it appears from our 
results that the post-procedural elevation in resting velocity observed on patients with 
impaired CFVR is a diffuse and a rather permanent phenomenon (Chapter III). The latter 
appears to be associated with higher systolic blood pressure values, age, and female 
gender proportion. In addition, higher resting velocities have recently found to be 
associated with more diffusely atheroschlerotic vessels. It might be possible that an 
elevated resting velocity is associated with higher risk patient's profile. 
Whenever a low absolute CFVR is encountered, an additional measurement of CVR in an 
adjacent, normal vessel as a reference value (CVR "'""'")can confirm the significance of 
the coronary lesion and compute the relative CFVR: 
Relative CVR= CVR absolute I CVR ccfcrcnco 
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Prior to an intervention, this new index has been highly correlated with the hyperaemic 
transtenotic pressure gradient. However, scant data is available about its prognostic value 
after an intervention. In chapter III, we report its clinical predictive value, particularly at 
short term, following balloon angioplasty and stent implantation. 
In chapter IV, a detailed analysis of patients with impaired post-procedural CFVR 
showed that diabetes and increasing age are independent predictors of a lack of 
normalization ofCFVR at 6 month-follow-up. 
Post-procedural coronary artery dissections are found in approximately 20 to 40% when 
assessed by angiography, and up to 80% with IVUS assessment. In chapter V we 
reported the hemodynamic impact ofunstented coronary dissections. We observed that 
patients with moderate dissections associated with a TIMI 3 flow and no signs or 
symptoms suggestive of angina had an impaired post-procedural CVFR. However, the 
latter was mainly due to an inappropriate elevation of the resting average peak velocity. 
Interestingly, this elevation vanished at follow-up, normalizing the CFVR. Therefore, it 
appears that moderate dissections do not impose a significant obstruction in coronary 
blood flow. This concept was further supported by the fact that similar relative CFVR 
were found in patients with and without moderate dissections (Chapter VI). 
In attempt to circumvent the various limitations encountered by our groups and others 
whenever using the absolute CFVR for clinical-decision making, we decided to search 
for a more lesion-specific Doppler-derived parameter. We investigated the post-
procedural coronary blood flow velocity acceleration at the stenotic site as an index of 
persistent residual stenosis. The absence of this acceleration predicted a functional 
improvement followiog balloon angioplasty (Chapter VII). Moreover, the presence of 
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stenotic velocity acceleration was strongly associated with a worst angiographic outcome 
(Chapter VIII). 
The blood flow, by virtue of viscosity, engenders on the luminal surface a frictional force 
per unit area known as hemodynamic shear stress. Shear stress inflicted on the healthy 
coronary endothelium induces an NO-mediated vasodilatation. Several reports have 
shown that the presence of elevated shear stress values inhibit and induces regression of 
neointimal formation. Moreover, shear stress has been shown to be a critical determinant 
of vessel calibre and the vascular remodelling process. Despite all these data, the impact 
of shear stress on the restenosis rate is currently unknown. In order to evaluate the 
restenosis rate according to shear stress levels, we analysed the DEBATE database. This 
database is rich in angiographic data performed by QCA (minimal luminal area, reference 
diameter, diameter stenosis) and videodensitrometry (cross-sectional area) as well as 
Doppler-derived data (CFVR, baseline and hyperaernic velocity prior to, after and at 6 
month follow-up angioplasty). From these data analysis, we reported that patients with 
elevated post-procedural shear stress values at the reference sites are associated with a 
worst clinical and angiographic outcome. These apparent paradoxical findings might be 
due to the presence of a local turbulent blood flow, which is known to be associated with 
an enhanced proliferative and thrombotic response. 
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Samenvatting en Conclusies 
De absolute reserve van de coronaire doorstromingssnelheid, de verhouding van hyperemische tot 
basale gemiddelde doorstromingssnelheid, wordt bij hartcatheterisatie gebruikt voor klinische 
besluitvorming en voor beter inzicht van de pathofysiologische processen die betrokken zijn bij 
ziekten zeals anger Prinzmetal, X syndroom, hypertrofie van het linker ventrikel, hypertensie, 
diabetes en acute coronair syndromen. 
Dit verhoudingscijfer is afhankelijk van de doorgankelijkheid van het epicardiale kanaal en de 
toestand van de microvasculaire circulatie. Bij afvvezigheid van obstructie van het epicardiale 
kanaal, kan de CVR (coronary velocity reserve; reserve van de coronaire snelheid) aileen 
afwijkend zijn op grand van een in gevaar gebrachte microcirculatie. Bijgevolg. een afwijkende CVR 
kan niet onderscheiden welke van de 2 componenten verantwoordelijk is voor vermindering van de 
doorstroming. Bij voorbeeld, bij gebnuikmaking van de databank DEBATE. die opeenvolgende 
Doppler gegevens heeft verzameld (voor, na en bij een vervolg-angioplastiek na 6 maanden), 
waren wij slechts in staat een kortstondige vermindering in hyperemische snelheid te constateren 
bij pati§nten met een verzwakte CFVR (coronary flow velocity reserve= reserve van de coronaire 
doorstromingssne/heid). De hyperemische verbetering waargenomen bij die patienten bij de follow-
up was niet gerelateerd aan geometrische veranderingen die plaats hadden gehad op de plek van 
de laesie. Bovendien, bij pati§nten die een ballon angioplastiek ondergaan en bij wie een 
additionele stent wordt aangebracht als onderdeel van de DEBATE II proef, hebben wij verder de 
twee oorzaken on~eed van de verlaagde hyperemische doorstromingssnelheid: 1) Onvoldoende 
veJWijding van het lumen na angioplastiek 2) Blijvende microvasculaire disfunctie na een adequate 
ontplooiing van de stent (Hoofdstuk Ill). 
Een andere waarschuwing die men tegen kan komen wanneer men gebruik maakt van de absolute 
CFVR na de ingreep is dat oneigenlijke verhogingen van de gemiddelde pieksnelheid in rust ten 
onrechte de actuele CFVR waarde verminderen. Verscheidene auteurs hebben voorheen 
verhogingen in de doorstromingssnelheden in rust beschreven als de voomaamste oorzaak van 
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een verminderde CFVR. Deze verslagen beschreven slechts kortstondige verhogingen, die 
verklaard zouden kunnen worden door een vertraging in de coronaire autoregulatie. Bovendien, in-
vitro en in-vivo studies hebben de aandacht gericht op coronaire micro-embolisatie als de oorzaak 
voor kortstondige verhogingen in rust van de bloedstroom, volgend op percutane interventies. Deze 
reactie schijnt te worden opgewekt door het vrijkomen van adenosine afkomstig van microvaten in 
de gebieden waar micro-embolisatie is opgetreden. In Hoofdstuk II beschrijven wij resultaten van de 
databank DEBATE I, die hogere doorstromingssnelheden van het bloed in rust Iaten zien voor, na 
en bij de follow-up ballon angioplastiek na 6 maanden bij patienten met een verminderde CFVR, 
vergeleken met de controlewaarden. Bovendien beschrijven wij een verhoging van de snelheid in 
nus! niet aileen in het behandelde gebied maar oak in het referentievat (Hoofdstuk Ill). Bijgevolg, uit 
onze bevindingen komt naar voren dat de verhoging na de ingreep in de snelheid in rust, 
waargenomen bij patiEmten met verminderde CFVR, een diffuus en min of meer permanent 
fenomeen is (Hoofdstuk Ill). Dit laatste schijnt te moeten worden geassocieerd met hogere 
systolische waarden van de bloeddnuk, leeftijd, en het vrouwelijk geslacht. Bovendien, onlangs is 
ontdekt dat hogere snelheden in rust in verband gebracht worden met meer diffuse 
atherosclerotische vaten. Mogelijk dat een verhoogde snelheid in rust verbonden is met het profiel 
van een patient met een hoger risico. 
Wanneer een lage absolute CFVR wordt aangetroffen, kan een aanvullende meting van de CVR in 
een aangrenzend, normaal vat als een referentiewaarde (CVRrererer~ce) de omvang bevestigen van 
de coronaire laesie en de relatieve CFVR berekenen: 
Relatieve CVR= CVRabsolutef CVRrererer~ce 
Voorafgaand aan een interventie wordt dlt nieuwe verhoudingscijfer in hoge mate gecorreleerd aan 
de hyperemische transstenotische drukgradi§nt. Echter, weinig gegevens zijn beschikbaar over de 
prognostische waarde hiervan na een interventie. In Hoofdstuk Ill beschrijven we de voorspellende 
waarde, in het bijzonder op de korte tenmijn, na ballon angioplastiek en implantatie van een stent. 
168 
Samenvatting en Conclusies 
In Hoofdstuk IV heeft een gedetailleerde analyse van patienten met venminderde CFVR na de 
ingreep aangetoond dat diabetes en gevorderde leeftijd onafhankelijke factoren zijn voor de 
uitblijvende normalisatie van de CFVR bij de follow-up na 6 maanden. 
Dissecties van de coronaire arterie na de ingreep zijn gevonden in ongeveer 20 tot 40 % van de 
gevallen, wanneer de beoordeling plaats vond d.m.v. angiografie, en tot 80 % met de beoordeling 
d.m.v. IVUS (intracoronaire vascu/aire echografie). In Hoofdstuk V hebben we de hemodynamische 
impact beschreven van coronair dissecties zonder het aanbrengen van een stent. We hebben 
waargenomen dat patienten met gematigde dissecties, gepaard gaande met een TIM I 3 stroming 
en geen tekenen of symptomen verdacht voor angina, een verminderde CFVR hadden na de 
ingreep. Echter, dit laatste was voomamelijk te wijten aan een oneigenlijke verhoging van de 
gemiddelde pieksnelheid in rust. lnteressant was dat deze verhoging verdwenen was bij de follow-
up en dat de CFVR genonmaliseerd was. Daarom schijnt het dat gematigde dissecties geen 
significante obstructie vormen in de coronaire bloedstroom. Deze opvatting werd verder gesteund 
door het feit dat soortgelijke relatieve CFVR's werden gevonden bij patienten met en zonder 
gematigde dissecties (Hoofdstuk VI). 
In een paging de verscheidene beperkingen te omzeilen, die we ontmoetten bij onze groepen en 
andere, wanneer we de absolute CFVR gebruikten voor de klinische besluitvorming, hebben we 
besloten te zoeken naar een parameter meer specifiek gericht op laesie, ontleend aan de Doppler. 
We onderzochten de acceleratie van de doorstromingssnelheid van het bleed in de coronaire vaten 
na de ingreep op de plaats van de stenose als een verhoudingscijfer van blijvende rest-stenose. 
Het uitblijven van deze acceleratie gal een functionele verbetering aan na de ballon angioplastiek 
(Hoofdstuk VII). Bovendien, het optreden van acceleratie van de stenotische snelheid werd sterk in 
verband gebracht met een zeer slecht resultaat van de angiografie (Hoofdstuk VIII). 
De bloedstroom, krachtens viscositeit, veroorzaakt aan de oppervlakte van het lumen een 
wrijvingskracht per oppeNiakte eenheid, bekend als de hemodynamische shear stress. Shear 
stress, uitgeoefend op het gezonde coronaire endotheel, veroorzaakt een vasodilatatie, door middel 
van NO (stikstofmonoxyde). Verscheidene verslagen hebben aangetoond dat de aanwezigheid van 
verhoogde shear stress waarden een belemmering vormt en leidt tot regressle van neo-intimaal 
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herstel. Bovendien, het is aangetoond dat shear stress een kritische beslissende factor is met 
betrekking tot de doorsnee van het vat en het proces van de vasculaire remodellering. Ondanks al 
deze gegevens, is de impact van shear stress op de restenose thans onbekend. Om de graad van 
restenose te evalueren volgens de shear stress niveaus, hebben we de gegevens van de databank 
DEBATE geanalyseerd. Deze databank bevat zeer vele gegevens over angiografie uitgevoerd door 
QCA (kwantitatief coronair angiogram) (minimaal gebied van het lumen, referentie diameter, 
diameter stenose) en videodensitrometrie (dwarsdoorsnede van het gebied), evenals gegevens 
ontleend aan de Doppler (CFVR, grondwaarde en hyperemische snelheid, voor, na en bij een 
vervolg-angioplastiek na 6 maanden). Op grand van analyse van deze gegevens, hebben we 
beschreven dat patienten met verhoogde shear stress waarden na de ingreep op de 
onderzoeksplaatsen geassocieerd worden met een zeer slecht klinisch en angiografisch resultaat. 
Deze ogenschijnlijk paradoxale bevindingen zijn mogelijk te wijten aan de aanwezigheid van een 
lokale turbulente bloedstroom, waarvan bekend is dat die wordt geassocieerd met een verhoogde 
proliferatieve respons en kans op trombose. 
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